Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download one vision2012 - University of Illinois College of Medicine at Chicago
Document related concepts
Contact lens wikipedia , lookup
Idiopathic intracranial hypertension wikipedia , lookup
Mitochondrial optic neuropathies wikipedia , lookup
Photoreceptor cell wikipedia , lookup
Visual impairment wikipedia , lookup
Blast-related ocular trauma wikipedia , lookup
Retinal waves wikipedia , lookup
Eyeglass prescription wikipedia , lookup
Macular degeneration wikipedia , lookup
Visual impairment due to intracranial pressure wikipedia , lookup
Vision therapy wikipedia , lookup
Keratoconus wikipedia , lookup
Dry eye syndrome wikipedia , lookup
Cataract surgery wikipedia , lookup
Transcript
Illinois Eye and Ear Infirmary UIC Department of Ophthalmology & Visual Sciences ONE VISION2012 IN THIS ISSUE A message from the DEAN 2 8 12 14 20 22 25 34 36 38 41 "I am pleased to welcome Rohit Varma, MD, MPH, as Chair of the Illinois Eye and Ear Infirmary, University of Illinois at Chicago Department of Ophthalmology & Visual Sciences and Associate Dean for Strategic Planning at the UIC College of Medicine. Dr. Varma is a highly accomplished physician-scientist and translational investigator who studies the development of eye diseases in minority populations and examines novel biological, genetic and lifestyle factors related to the risk of developing eye diseases. He is an expert on changes in the optic nerve in glaucoma and on new imaging techniques in the early diagnosis of glaucomatous optic nerve damage. Under his leadership, the Department of Ophthalmology & Visual Sciences begins a new era of clinical and research excellence." News Innovations Patient Profile Giving Endowment Activity Faculty Publications Sponsored Research Clinical Investigations and Trials Residents and Fellows Alumni Dimitri T. Azar, MD, MBA | Dean, College of Medicine Dean Dimitri Azar (left) and Dr. Rohit Varma CREDITS Managing Editor Julie Daraska Editors Carol Chaplin & Margaret Doyle Designers Studio Deluxe & Lisa Birmingham Contributors Margaret Chervinko, Laurie Walker Candace Pearson & Margaret Doyle Photography Cathy Carroll, Joshua Clark, Roberta Dupuis-Devlin, Mark Janowicz & Walter Urie One Vision 2012 1 A message From the Department Chair "I am deeply honored by the trust that Dean Azar has placed in me to lead the Illinois Eye and Ear Infirmary, UIC Department of Ophthalmology & Visual Sciences to a new era of educational, clinical and research excellence. It is a privilege to be a part of the Illinois Eye and Ear Infirmary, known for generations as an outstanding center of clinical expertise and innovative research. "Among our key priorities is strengthening the resources available for resident education — evidenced by the dedication of substantial space for the new Resident Education Center that will house a state-of-the-art surgical simulator. Together with our clinical faculty, we will build a structured surgical curriculum that spans the entire three years of residency, beginning with early exposure to ophthalmic surgery through the EyesiTM surgical simulator, wet labs and lectures and discussions with our most senior and renowned surgeons. By the time our residents graduate, they will have experience as primary surgeons in all of our subspecialties. "This educational experience requires investment of considerable time and energy on the part of our faculty. With their invaluable commitment, the Illinois Eye and Ear Infirmary will continue to be ranked among the most competitive residency programs in the country. "In ophthalmology education, as in practice, the technologies that advance our ability to diagnose, treat and manage blinding eye diseases require substantial monetary investment. We are grateful to the College of Medicine for the program to fund measurable improvement in medical education. We are indebted to our alumni and donors for their continued support and interest as we guide the Infirmary to a new era." Rohit Varma, MD, MPH | Professor and Department Chair Rohit Varma, MD, MPH Clinical Fellowship in Glaucoma Doheny Eye Institute University of Southern California Residency in Ophthalmology Wilmer Ophthalmological Institute The Johns Hopkins University School of Medicine Research Fellowship in Glaucoma Wills Eye Hospital Internship Union Memorial Hospital Masters in Public Health The Johns Hopkins Bloomberg School of Public Health Medical Degree Maulana Azad Medical College University of Delhi 2 NEWS Light-sensitive molecule Signaling retinal cells to respond to light UIC vision scientists and chemists recently created a light-sensitive molecule that can stimulate cells of the retina — a photochemical on-off switch that someday may lead to new treatments for degenerative eye diseases such as agerelated macular degeneration (AMD). Diseases such as AMD destroy photoreceptor cells that sense light and start the visual process. However, other retinal cell types, while not normally photosensitive, often remain healthy. “We asked ourselves, ‘Could we make healthy retinal cells responsive to light and bypass dead photoreceptor cells?’” says David Pepperberg, PhD, SearlsSchenk Professor of Ophthalmology and Director of the Photoreceptor Research Laboratory. Remarkably, the answer seems to be “yes.” The team’s focus: a neurotransmitter known as GABA (gamma-aminobutyric acid) that activates a receptor protein involved in visual signaling within the retina. The researchers synthesized new compounds built upon the anesthetic propofol, a small molecule that binds to and regulates GABA receptors. The new molecule is known as MPC088. As light of different wavelengths strikes it, MPC088 changes shape and functions essentially as a light switch for the GABA receptor. “It’s the outcome of many attempts,” says Dr. Pepperberg, Principal Investigator of David Pepperberg, PhD the study, which won funding from the National Eye Institute. The UIC chemists led by Karol Bruzik, PhD, Professor, College of Pharmacy, soon realized they had produced a molecule with broader implications. That sparked a collaboration with scientists at the University of California, Los Angeles (UCLA), led by Thomas S. Otis, PhD, Department of Neurobiology, who are exploring MPC088’s potential to reduce epileptic seizures. Turning the light switch off is also critical. Next for the UIC team is an attempt to program in “temporal tuning” and make the molecule revert back within a certain timeframe — essential for future clinical applications. The team also wants to incorporate a targeting component — a cellular GPS — to boost MPC088’s affinity for reaching the appropriate receptor site. “It’s a major challenge,” says Dr. Pepperberg, “but we’re excited to be pursuing what we believe is a promising approach.” The findings were published online in November in the journal Nature Communications. The paper’s co-first authors were Lan Yue, PhD, and Michal Pawlowski, PhD, UIC; and Shlomo S. Dellal, PhD, UCLA. In addition to the National Institutes of Health, the study has received key support from the Daniel F. and Ada L. Rice Foundation, the Arnold and Mabel Beckman Initiative for Macular Research, American Health Assistance Foundation, Hope for Vision, Research to Prevent Blindness, and the UIC Center for Clinical and Translational Science. OH OH O N H N O Propofol OH O N H N N H N MPC088 O H N O O 24 O N H N O MPC100 O O N H N O NH2 N H N N H NH2 N MPD021 Chemical structures, including light-sensitive MPC088 (top). Reprinted with permission of Nature Communications. One Vision 2012 3 corneal Stem cells Transplants open a window on the future For 43-year-old Shawn Doyle, gradually losing the sight in his right eye was like looking out on the world “through a dirty window or wax paper.” His worsening vision — caused by a deficiency of corneal limbal stem cells — made it harder to do his work as a motorcycle and boat mechanic, enjoy outdoor sports or even drive. Then, Ali Djalilian, MD, told him about a limbal stem cell transplant. “I was intrigued and excited,” says Shawn. “Over the last 10 years, we’ve been learning more and more about the concept of limbal stem cell transplants and improving on the outcomes,” says Dr. Ali Djalilian, Associate Professor and Director, Corneal Epithelial Stem Cell Biology and Tissue Engineering Laboratory. Limbal stem cells are found at the edge of the cornea. Injuries and genetic or immunological diseases can destroy the surface and, with it, limbal stem cells. The result is visual impairment or even blindness. The problem can’t be solved with a standard cornea transplant, which contains no stem cells. Surgeons harvest the cells and surrounding environment from various sources: the patient’s other eye, if healthy; a living relative; and cadaver tissue, the source of Shawn’s new stem cells. Dr. Djalilian’s latest innovation is the use of a biological glue made from proteins in the blood clotting system to secure the transplant without any sutures. The glue has been used in other forms of surgery, but not limbal transplants. The result is increased comfort for the patient and less inflammation. The program’s approach to medical management after transplant also “distinguishes us from other centers,” says Dr. Djalilian. That includes careful use of immunosuppressants to control rejection. Often, specialists in glaucoma, oculoplastics and organ transplant join the team, as needed. Since his stem cell transplant in November, Shawn’s eyesight has Corneal stem cells, pictured here, are used to grow cells in the laboratory to study their protein expression and cellto-cell communications that contribute to their function. been improving daily. He can read a newspaper without the aid of glasses or contact lenses. “It’s been a great miracle,” he says. Working in the lab, Dr. Djalilian and his colleagues are hoping for another breakthrough: finding a way to replace limbal stem cells with a patient’s own cells from elsewhere in the body. Using a patient’s own cells would eliminate the problems of transplant rejection and immunosuppression. So far, the investigators have succeeded in getting other cells to change into limbal cells — but the switch is temporary. One theory is that the cells need the entire corneal environment to mimic limbal cells. “That’s the main focus of our research now,” says Dr. Djalilian, “recreating that environment, ‘the limbal stem cell niche.’” 4 NEWS Team APPROACH Collaboration improves outcomes of pediatric eye trauma Severe eye injuries in children frequently affect multiple parts of the eye and require skill sets different from those more commonly applied in adults. So it makes sense that the best outcomes can be achieved when a team of subspecialists work together to pool their expertise. The Illinois Eye and Ear Infirmary has developed an innovative team approach to treating children with traumatic eye injuries. Within two days of being treated for an open globe injury, a trauma patient in the Pediatric Ophthalmology clinic is examined by Iris Kassem, MD, PhD; Javaneh Abbasian, MD (pediatric glaucoma specialist); or Genie Bang, MD (pediatric cataract specialist), to identify potential complications, establish early treatment for amblyopia and coordinate subspecialty care. Felix Chau, MD, and Yannek Leiderman, MD, PhD, provide the team’s retinal expertise, specializing in such problems as bleeding inside the eye, retinal detachment, dislocation of the lens, and foreign objects such as metal or wood entering the eye from trauma. “Sometimes it is evident from the outset that the injury involves the back part of the eye,” notes Dr. Leiderman. “Other times, it is difficult to assess the Early intervention can help identify potential complications from eye injuries. extent of the damage because of the presence of blood within the eye or injury to the cornea or lens.” A multidisciplinary team approach is equally important in such cases, so any injury can be treated appropriately in the operating room, when all of the surgeons having the necessary expertise are available. Most children see a retinal specialist, whether or not the original trauma caused a retinal problem, because visualization of the retina is critical before the development of traumatic cataracts — a frequent occurrence in children with an eye injury. Aisha Traish, MD, who specializes in pediatric cornea, often collaborates in the patient’s care to optimize corneal healing. “Each child has the most comprehensive care from the start,” says Dr. Traish. “Our common goal is the best possible long-term visual function.” Ahmad A. Aref, MD, is brought in if glaucoma develops. Ellen Shorter, OD, or Timothy McMahon, OD, provide consultation on contact lenses after a child’s initial surgery. “Successful fitting of a contact lens is critical in children who have had ocular trauma and are now aphakic (have no lens in the eye), to provide the best possible vision and to prevent amblyopia,” notes Dr. Shorter. “By working closely with other members of the team, we can provide excellent care,” says Dr. Leiderman, “but we also have the opportunity to learn from one another, to discuss novel approaches, and to explore new concepts pioneered in other fields.” One Vision 2012 5 artificial cornea Complicated cases benefit from program’s expertise Artificial cornea An artificial cornea is proving to be the gift of sight for many people with complicated conditions for whom traditional corneal tissue transplants have either failed or have a poor prognosis. The Illinois Eye and Ear Infirmary is home to the largest artificial cornea program of its kind in the Midwest, with more than 120 patients receiving implants to date. The program uses the Boston Keratoprothesis (k-pro), the most popular artificial cornea worldwide. “We promote an interdisciplinary approach, with our patients able to take advantage of our large department and expertise,” says Soledad Cortina, MD, Assistant Professor and Director of the Artificial Cornea Program. As a cornea surgeon, she heads a team that includes experts in glaucoma, retina, oculoplastics, contact lenses and pediatric ophthalmology, as needed. Initially, the artificial cornea — which received U.S. Food and Drug Administration approval in 1992 — was reserved for people with blindness in both eyes. Recently, less severe cases have realized excellent results. “I have patients who have been blind for decades and with this artificial cornea their vision and the quality of their lives has significantly improved,” says Dr. Cortina. Bobby Wallace, 47, is one of those beneficiaries. At age 23, he suffered a devastating loss of sight from a chemical burn to both eyes. With his left eye, he could read large type close to his face. His right eye — the more severely injured, with significant scarring — only perceived light. Over time, he had a limbal (corneal) stem cell transplant and cornea transplant in his left eye using tissue from a human donor. Both procedures, performed at another institution, failed. In 2011, Bobby came to the Illinois Eye and Ear Infirmary, where reconstructive surgery restored the surface of his right eye. Then, Dr. Cortina implanted the artificial cornea in the place of Bobby’s damaged natural cornea. When the k-pro’s three parts are assembled, it has the shape of a collar button. Because its central portion is made of plastic, the k-pro eliminates the issue of rejection that occurs in human tissue transplants. When the patch came off Bobby’s right eye following surgery, he saw his wife, Sheila, for the first time. Later, on the way home, he was able to read billboards. “Being able to see has given me such a boost in my self-confidence,” says Bobby. Before the implant, Bobby couldn’t enjoy such ordinary pleasures as reading his Bible or watching a movie. He says, “It sounds simple, but it’s a big blessing to me.” “I have patients who have been blind for decades and with this artificial cornea their vision and the quality of their lives has significantly improved.” –Dr. Soledad Cortina Soledad Cortina, MD, left, with Samuel Lee, MD 6 news Aaron Jackson Return to Independence "My eyes are still improving, but I’ve come so far. I no longer need anyone to help me get to the store or take me to work." –aaron jackson Aaron Jackson has been an employee of UIC since 2000 and currently serves as the Assistant Facilities Manager for the East Campus. So when he began experiencing vision problems a few years ago, he naturally sought out the expertise of doctors at the Illinois Eye and Ear Infirmary, who were able to diagnose and treat his worsening glaucoma. Surgery was performed to stabilize the glaucoma and remove cloudy cataracts, but Aaron had permanent vision loss as a result of irreparable damage to the optic nerve that occurred before his diagnosis. In November 2010, he began seeing Joan Stelmack, OD, MPH, FAAO, Director of UIC’s Low Vision Service, to learn how to function with diminished vision. The Department of Ophthalmology & Visual Sciences established the Low Vision Service to provide rehabilitation services for patients with permanent vision loss. Dr. Stelmack works with a low vision optometrist and a certified low vision therapist to provide patients with clinical examinations and visual skills assessments. Patients with low vision are introduced to technology and techniques that enhance their remaining sight and give them new visual skills to tackle the routine tasks of everyday life and put them on the path to independence. “I saw Dr. Stelmack for corrective therapy,” explains Aaron. “She taught me how to recalibrate my eye movement, coordination and balance.” “Vision rehabilitation was needed to increase independence in activities of daily living and to explore vocational and recreational adaptations,” notes Dr. Stelmack. According to Dr. Stelmack, the treatment goals for Aaron included being able to use a computer for work and recreation, the capability to read small print such as time cards and mail and the ability to navigate safely in Aaron Jackson with Dr. Joan Stelmack poor lighting conditions. Aaron was prescribed low vision devices to enhance his remaining vision, including reading glasses, glasses for distance and a magnifying glass to see small print. Most patients who undergo vision rehabilitation therapy achieve improved visual function. Unfortunately, patients are not always aware of all the options that may improve their visual function after serious eye surgery. Today, Aaron only sees Dr. Stelmack when functional problems arise. But those issues occur less frequently now. “My eyes are still improving, but I’ve come so far,” says Aaron. “I no longer need anyone to help me get to the store or take me to work.” Along with his independence, Aaron has returned to his favorite pastime: photography. One Vision 2012 7 A combination of drugs delivered in a novel “steroid ball” decreased the number of additional Lucentis® injections for patients in a unique pilot study. AMD treatment Novel drug delivery combo addresses macular degeneration Age-related macular degeneration (AMD) affects more than 1.75 million people in the U.S. With a rapidly aging population, experts expect this number to reach 3 million by 2020. There is no cure. However, new treatments have emerged to offer improved prognosis, based on the discovery that a group of proteins in the body called vascular endothelial growth factors (VEGF) play a role in formation of abnormal blood vessels that damage the retina. Anti-VEGF inhibitors have been shown to prevent vision loss and improve clearness of vision in patients with neovascular or “wet” AMD, the more severe form. However, frequent injections are required, anywhere from once to several times a month, depending on the patient. Jennifer I. Lim, MD, Professor and Director of the Retina Service, thinks she may have an answer in a new combination of drugs and a novel slow-release, longlasting drug delivery system. The drug delivery system, Verisome® from Icon BioSciences, Inc., is a biodegradable liquid that may be combined with other drugs and then injected into the eye using a standard needle. Dr. Lim recently completed a small pilot study that combined Lucentis® (ranibizumab), a leading anti-VEGF drug, with Verisome using triamcinolone acetonide (TA), an anti-inflammatory drug that helps prevent blood vessel growth. The TA along with the Verisome was delivered as a single injection into the eye. The combined product coalesces into a single sphere — essentially a “steroid ball,” explains Dr. Lim, In the pilot study completed in December, 10 participants received an injection of Lucentis as a baseline treatment, then, a week later, an injection of the liquid steroid ball. The biodegradable vehicle provides controlled, extended drug release for up to one year. “The combination of this drug ball with an initial Lucentis injection enables us to decrease the number of Lucentis injections needed,” says Dr. Lim. “We are the only place in the world to use this delivery system with this combination therapy.” The number of additional Lucentis injections needed was cut in half by the treatment used in the pilot study. There were few side effects and no serious adverse ocular events. Retina Service physician-scientists are actively exploring other innovative AMD solutions, including Eylea® (aflibercept), the newest anti-VEGF drug approved by the U.S. Food and Drug Administration. UIC also is a participant in the nationwide Age- Liquid-release drug delivery system in eye Related Eye Disease Study 2 (AREDS2), which is looking at the effectiveness of a combination vitamin A and Omega-3 fish oils, along with other formulas, for slowing the progression of AMD. “We are the only place in the world to use this delivery system with this combination therapy.” –Dr. Jennifer Lim 8 Innovations CLINICAL STUDIES open way for New treatment for retinal disease Testing efficacy of donated corneas Drug discovery efforts within the Retina Chemical Genomics Lab, directed by Michael Grassi, MD, Assistant Professor, recently accelerated. In work published earlier this year in Investigative Ophthalmology & Visual Science (doi: 10.1167/ iovs.11-8928), Qing Chang, MD, PhD, Research Assistant Professor, and Dr. Grassi developed a cell-based model for retinal degenerative key pathways that are responsible for cell death in photoreceptors, the light-sensing cells of the retina. This model has subsequently been leveraged by Dr. Chang and Dr. Grassi to screen a U.S. Food and Drug Administration-approved compound library of more than 1,000 compounds to identify new treatments for retinal disease. Work is underway to better define the mechanism of action for a novel compound identified in this screen, which could potentially represent a new treatment for retinal disease. “For those individuals suffering from retinal disease, these studies reveal the exciting advantages of high-throughput screening platforms, which are accelerating our ability to introduce new treatments in the clinic,” states Dr. Grassi. The Illinois Eye and Ear Infirmary is among the sites participating in the Cornea Preservation Time Study (CPTS), a $12.3 million study to determine whether the supply of donated corneas can meet anticipated growth in demand over the next 20 to 30 years. Elmer Tu, MD, Associate Professor and Director of the Cornea Service, serves as site director of the study, which will determine whether corneas transplanted up to two weeks after donor death work as well as corneas transplanted up to one week after donor death. The growth of the U.S. population which accounts for the majority of corneal transplants — patients 50 and older — is projected to increase from about 99 million in 2010 to about 133 million by 2030, according to the U.S. Census Bureau. Many cornea transplant specialists are concerned about an adequate supply of donated corneas. One approach to solving the projected increase is to prove that donated corneas up to two weeks old achieve the same outcomes for patients as those that are transplanted a week after donor death. According to Dr. Tu, most cornea surgeons use corneas up to one week after the death of the donor, even though the U.S. Food and Drug Administration permits corneas to be stored in preservation medium at refrigerator temperature up to two weeks after donor death. Corneas older than two weeks are used overseas for transplants without significant problems reported, he adds. “We want to see if the length of time the donor cornea is kept in the preservation liquid before the transplant affects the likelihood of the transplant being successful.” Participants will be followed for three years after transplant to see if there are differences in transplant success or in the number of transplanted endothelial cells (the layers of cells that line the undersurface of the cornea) on the corneas that were preserved for seven days or less compared to those Michael Grassi, MD One Vision 2012 9 new treatments Elmer Tu, MD Yannek Leiderman, MD, PhD preserved between eight and 14 days. “There is no reason to believe there is any greater risk for transplant failure with either preservation time group,” Dr. Tu said. The study is headed by Jonathan Lass, MD, Chair of the Case Western Reserve Department of Ophthalmology & Visual Sciences. The project is in collaboration with a major effort by Joe G.N. “Skip” Garcia, MD, Vice President for Health Affairs at the University of Illinois, to build a broad range of biomarkers for disease. The UI BioBank will provide a database for the correlation of clinical samples with phenotypic data for the purpose of investigative analyses and to provide access to study data for future protocols and investigations. The patient cohort for Dr. Leiderman’s study includes outpatients in the Illinois Eye and Ear Infirmary who have diabetes or conditions associated with proliferative retinopathies and patients that have opted to participate in the UI BioBank and have undergone blood collection in the course of their clinical care. He and research colleague Bin Liu, PhD, are coordinating sample collection with the Retina Service physicians. Building biomarker database Yannek Leiderman, MD, PhD, Assistant Professor and Director of the Vitreoretinal Microsurgery Laboratory, is implementing a system of large-scale sample collection, including storage of whole blood, DNA, RNA, plasma and serum, as well as a clinical database that will be utilized to investigate the relationship of biomarkers with health and diabetic retinopathy status and progression. 10 Innovations New technologies Staying state-of-the-art With the acquisition of the EyesiTM surgical simulator, the Illinois Eye and Ear Infirmary made a million-dollar investment in new technologies for teaching, patient care and research. “As a world-class program, we must employ state-of-the-art technologies in every aspect of our mission,” states Rohit Varma, MD, MPH, Professor and Chair, Department of Ophthalmology & Visual Sciences. “My commitment is to ensure we have the resources to stay on the leading edge of biomedical technologies in ophthalmologic care and vision research.” Training enhanced by surgical simulator Acquisition of the EyesiTM surgical simulator is the core component of infrastructure and design upgrades in a state-of-the-art Resident Education Center. Residents and Fellows can practice intraocular surgery in a closeto-real setting, available on demand at all times. The Eyesi surgical simulator provides direct feedback to the surgeon and clearly indicates any areas of deficiency, allowing for self-assessment and improvement. “Tools such as the Eyesi and wet and dry lab kits for surgical training give us a distinct advantage in preparing our residents for ophthalmology practice,” says William Mieler, MD, Professor and William Mieler, MD Vice Chair for Education. “The longterm impact will be markedly beneficial to our patients.” Powerful laser scanning microscope aids research A state-of-the-art Zeiss Confocal Laser Scanning Microscope (LSM) 710 is giving Department investigators advanced imaging capabilities, including time-lapsed imaging to study cell interactions and migration. The high-resolution microscope was purchased last spring with support from The Cless Family Foundation, the Core Grant for Vision Research from the National Eye Institute, and Research to Prevent Blindness, Inc. Ali Djalilian, MD, uses the Zeiss LSM 710 to study the changes that take place in corneal cells during wound healing. “The impressive quality of the images allows us to see fine changes over time, something we had previously been unable to do.” J.H. Robert Chang, PhD, and Kyu Yeon Han, PhD, employ the Zeiss LSM 710 to track green fluorescent protein molecules in ocular cells. They are trying to detail aberrant corneal blood and lymphatic vessel growth after injury and infection, the main causes of corneal transplant rejection and blindness. “The LSM 710 microscope allows us to achieve a fundamental understanding of these mechanisms,” says Dr. Chang. “The results will provide therapeutic intervention to prevent and treat devastating, blinding eye diseases.” Together with the imaging facility’s live-cell microscopy system, the new microscopy system is a valuable resource for generating new basic science knowledge “that is essential to improve understanding and treatment of various eye diseases,” says Mahnaz Shahidi, PhD, Vice Chair for Research and Director of the Applied Physics Laboratory. One Vision 2012 11 Left to right: Samuel Lee, MD, Joann Kang, MD, and Jose de la Cruz, MD Laser-assisted surgery benefits teaching mission For Joann Kang, MD, Co-Chief Resident at Illinois Eye and Ear Infirmary, performing cataract procedures using the latest advance in laser-assisted surgery is “a confidence builder.” With the Alcon LenSx® Laser System as a surgical tool, Dr. Kang can hone her skills at the beginning of her learning curve. “As someone in training, parts of the surgery can be more difficult than others. The laser can assist at those points, making the rest of the surgery easier and ensuring consistency from procedure to procedure.” The Illinois Eye and Ear Infirmary is the first academic center in the Midwest to offer the laser-assisted technology to patients and the first and only center to provide access to the LenSx system to its residents and fellows. The technology, used for years in refractive surgery, recently won U.S. Food and Drug Administration approval for cataract surgery. “We’re changing the traditional thinking,” says Jose de la Cruz, MD, a member of the Cornea Service and an early enthusiast for laserassisted surgery. Typically, medical centers reserve new technologies for experienced faculty. “Having access to the LenSx system allows our residents and fellows to be more creative and to progress in their skills that much more quickly,” he explains. The system offers decided advantages for patients as well, including precision, consistency and less time in the operating room. The laser provides real-time, 3D images to guide the procedure and allows the surgeon to make an incision at the micron level. It also offers more stability and accuracy as the surgeon creates a perfect circular hole to enter, cut the lens and remove it, then center the intraocular lens. In traditional cataract surgery — which still represents the bulk of training for residents — a manual blade is used. The laser sends energy at an extremely short burst known as a femtosecond. For comparison, a femtosecond is to a second what a second is to 31.7 million years. “We haven’t done clinical studies yet, but in our surgeries we have noticed less post-surgery inflammation and a quicker recovery,” says Dr. de la Cruz, Assistant Professor and Director of the Millennium Park Eye Center, the university’s downtown satellite clinic. Cornea and Refractive Surgery Fellow Samuel Lee, MD, appreciates the opportunity the laser system gives him to “think more innovatively.” From his point-of-view, the LenSx levels the playing field for cataract surgeons. “We’re the younger generation of ophthalmologists who will be doing cataract surgery over the next 30 years,” says Dr. Lee. “It’s nice that this technology isn’t just reserved for senior surgeons. We’re the ones who will use it for years to come.” Top: Cross-sectional optical coherence tomography (OCT) image showing where corneal incisions will be made and in what pattern. Bottom: OCT image with the highlighted treatment plan of the cataract. 12 Patient Profile One Vision 2012 13 TYLER BURRESS: Back in the game On Christmas Day 2011, Tyler Burress was accidently punched in his eye while playfully wrestling with a cousin. According to Tyler’s mother, Dana, the blow did not leave a bruise and did not seem to be a cause for concern. However, a few days later Tyler told his mother that he was seeing things floating in his right eye. Shortly after, he told her that he could not see anything at all except for blackness. Tyler’s parents took him to see a local eye doctor in their hometown of Danville, Illinois. He was sent to a retinal specialist who determined that Tyler had sustained blunt trauma to his right eye, which quickly developed into a large retinal tear. To treat his complicated condition, Tyler was referred to Yannek Leiderman, MD, PhD, at UIC’s Retina Service in Chicago. “These types of complex retinal detachments can be challenging to repair, particularly in children,” says Dr. Leiderman. He adds that while surgically repairing a retinal detachment is a common procedure performed by retina surgeons, maintaining the health of the eye and achieving good visual outcomes is more difficult in children and young adults. This was the primary reason Tyler’s retinal specialist referred him to the experts at the Illinois Eye and Ear Infirmary. Upon examining Tyler, Dr. Leiderman recommended immediate surgery. Despite the fast turn of events, Tyler’s parents were unfazed. “I was confident we were in the best place,” says Dana. The following day, Dr. Leiderman performed eye surgery (pars plana vitrectomy) to reattach Tyler’s retina. “The surgical procedure was a success,” says Dr. Leiderman. “And while Tyler has not regained perfect vision, he has made great progress and continues to improve.” “Tyler’s eye is healing very well,” says Dana, noting that there is no scar tissue. The toughest part for Tyler was Left: Dr. Yannek Leiderman of the Retina Service examines Tyler Burress. The Burress family with Dr. Leiderman keeping his head down for two weeks to maintain the gas bubble behind his eye that held his retina in place. “His vision is getting better,” says Dana, “although he sees wavy lines that may or may not go away.” Gradual vision improvement is typical following the surgical treatment of retinal detachment involving the critical central part of the retina. In the meantime, Tyler, an active 18-year old, is considering community college to pursue other interests until he finds out whether his vision will improve enough to join the Marines. “Tyler is a success story because we were able to restore his vision and help a young man continue to achieve his goals,” says Dr. Leiderman. He credits the skills of the entire UIC team who assisted in the treatment to save Tyler's sight. “It is a privilege to work as part of a team, including surgeons, anesthesiologists, nurses, technicians and many others here at UIC that allow us to care for the most challenging and complex cases,” adds Dr. Leiderman. 14 GIVING Panton family professorship ensures excellence in ophthalmology FOR GENERATIONS TO COME John H. Panton, MD, Res ’57, an ophthalmologist who completed his residency at the Illinois Eye and Ear Infirmary, made a $250,000 pledge to establish the Panton Family Professorship, which will help the Department of Ophthalmology & Visual Sciences recruit and retain top faculty. Matching funds from the Raymond Nester Sweeney, MD, Med ’68, estate will complete the $500,000 needed for an endowed professorship. Dr. Sweeney was a radiologist who spent most of his career practicing in Terre Haute, Indiana. Grateful for his education at the College of Medicine, Sweeney made an estate gift of nearly $20 million, which has created an endowment fund to provide student scholarships and to establish endowed professorships, such as the Panton Family Professorship. The Panton Family Professorship will be fully funded in 2016. Dr. John Panton is joined in making the gift by his wife, Mary Karakourtis Panton, his two sons, Peter J. Panton, MD, Res ‘86, and Robert W. Panton, MD, Res ‘90, and his daughter, Elizabeth Panton Karkazis, OD, an optometrist. They are in practice together at the Panton Eye Center in Elmwood Park, Illinois. The Panton family has a long history with the University of Illinois, both the Chicago and Urbana campuses. Dr. Peter Panton describes his family’s education pedigree as “a journey from Ellis Island to the Ivy League, with all roads passing through the University of Illinois.” His grandfather, Angelos Karakourtis, emigrated from Greece to the United States, passing through Ellis Island and arriving in Chicago in 1913. He lived in Chicago’s old Greektown, which adjoins UIC’s East Campus, and learned to read and write English at Hull House. Angelos’s daughter, Mary Karakourtis, was a member of the first class to enter the University of Illinois at Chicago in 1946 and attended classes there until 1948 when she transferred to the Urbana campus to complete her BA. She and Dr. John Panton, who graduated from the University of Athens School of Medicine and completed his residency in ophthalmology at Presbyterian Hospital of the City of Chicago, a teaching affiliate of the University of Illinois College of Medicine, were married in 1955. Their sons, Peter and Robert, both attended Brown University as undergraduates and Brown University School of Medicine; both did their ophthalmology residencies at the Infirmary. Daughter Elizabeth graduated from the University of Illinois, Urbana before earning her OD at the Illinois College of Optometry. Christina Panton, Peter’s daughter, has started medical school at Brown. One Vision 2012 15 From left: Dr. John H. Panton, Mary Karakourtis Panton, Dr. Elizabeth Panton Karkazis, Dr. Robert W. Panton and Dr. Peter J. Panton Mary Karakourtis Panton would often tell her children that “Excellence is permanent.” This was how she paraphrased her husband, who was fond of quoting Aristotle: “We are what we repeatedly do. Excellence, then, is not an act, but a habit.” The success of the Panton Eye Center and the family’s history of giving to the Department of Ophthalmology suggest they took her advice to heart. Dr. John Panton speaks warmly of the doctors who trained him, in particular Dr. William F. Hughes and Dr. Peter C. Kronfeld. Pointing to the facility in which he and his children have practiced for the past 20 years, he said, “All that we have here, all that we do here, is because of the good teachers at the Infirmary.” “You want to give back to the institutions that made your success possible,” said Dr. Peter Panton. “We want to help the place where we learned ophthalmology.” The Panton family’s history of giving to the Department of Ophthalmology dates back to the 1980s when they contributed to the effort to build the Lions of Illinois Eye Research Institute. In the past decade, they contributed to endowed professorships for Drs. Morton F. Goldberg, Joel Sugar and Jacob T. Wilensky. In 2007, Peter and Robert Panton joined with the children of Arnold D. Curnyn, MD, Res ’65 (Kimberlee M. Curnyn, MD, Res ’95), the late Harold Q. Kirk, MD, Res ’53 (Ann Kirk Williams, MD, Res ’87 and her husband Douglas P. Williams, MD, Res ’87), and Karl E. Ticho, MD, Res ’57 (Benjamin H. Ticho, MD, Res ‘91), to establish the Four Fathers Lecture in Ophthalmology. The Panton family also established a professorship in Modern Greek Studies at UIC. They have given generously to the National Hellenic Museum, located near UIC in Chicago’s Greektown. “We are so grateful to the Panton family for their generosity as loyal alumni of the Illinois Eye and Ear Infirmary,” says Dr. Rohit Varma, Department Chair. “We are what we repeatedly do. Excellence, then, is not an act, but a habit.” – Aristotle 16 GIVING Cless Best of the Best medal; Ruth and Gerhard (Gary) Cless CLESS FAMILY FOUNDATION Champions among donors Since 1995, when Gerhard (Gary) Cless first came to the Illinois Eye and Ear Infirmary for follow-up care after surgery to treat a macular hole, he has taken an active interest in the Department of Ophthalmology & Visual Sciences's research, providing extraordinary support through a variety of gifts. A native of Stuttgart, Germany, Gary is Executive Vice President and co-founder of Zebra Technologies Corporation, a global leader in Barcode and Radio Frequency Identification (RFID) technology. He holds several U.S. patents related to the RFID industry. He and his wife, Ruth, formed The Karl Cless Family Foundation, named for his father, through which they direct their philanthropic activities. In 2000, Gary donated a $50,000 high-powered confocal microscope, only the third of its kind installed in the United States at that time, and provided $70,000 for two research studies about macular holes. In 2001 he donated a Zeiss Optical Coherence Tomographer, imaging technology that allows doctors to better evaluate the disease progression and monitor treatment of patients. In 2012, support from The Cless Foundation made it possible to acquire the latest confocal microscope technology, a Zeiss laser scanning confocal system. In between, Gary has generously supported the Department’s research and education program, providing support for acquisition of other advanced microscopy for research, recruitment of retina faculty, clinical studies in diseases of the retina and macula, and for a retina fellow. Prior gifts established an endowed lecture, the Gerhard Cless Endowed Lecture in 2003, given at the annual retina meeting, and the Cless Best of the Best Award in 2008, which recognizes the best quality talk given at the annual meetings of the American Association of Ophthalmology and the Association for Research and Ophthalmology. The Cless Family Professorship in Ophthalmology is the latest gift from The Cless Family Foundation. The endowed professorship will be fully funded in 2013, with matching support from the College of Medicine’s Sweeney fund. “Gary and Ruth Cless have given more than $2 million to help the Department,” says Dr. Rohit Varma, Ophthalmology Chair. “We are deeply grateful for their contributions to vision research, which has impact well beyond our institution.” One Vision 2012 17 WHY I GIVE Chuck Barsky donates on behalf of his father Although he was just a teen at the time, Chuck Barsky vividly remembers his father, Albert, struggling for years with failing eyesight. A serious flare-up the day after his brother’s wedding caused Albert to lose most of his eyesight for the second time within 10 years. A trip to the local eye doctor in the Chicago suburbs confirmed that his case was extremely serious and required advanced attention. Albert was referred to the Department of Ophthalmology & Visual Sciences at UIC. “We consider ourselves fortunate to have been close to UIC, one of the leading eye institutes,” notes Chuck. Albert met with Jacob Wilensky, MD, Professor of Ophthalmology. Dr. Wilensky diagnosed Albert with acute glaucoma. After 25 years and more than 20 surgeries, including cornea transplants, Albert has regained some of his sight. According to Chuck, he can see roughly 25 percent out of one eye and has pinpoint vision in the other. “We give all the credit in the world to the doctors at UIC,” says Chuck. “We would never have dreamed that my father could one day see well enough to shoot baskets with his grandson.” Today, Albert regularly sees Dr. Wilensky and Joel Sugar, MD. Albert typically returns to UIC for treatment every three to six months. Chuck is grateful to the Department’s doctors for partially recovering his father’s eyesight, and feels that it is important to give back. “We owe so much to them,” he notes. Chuck earmarks his donation (which is matched by his employer, Discover Financial Services) for the Jacob Wilensky, MD, Endowed Glaucoma Research Fund, which is used for glaucoma research and the Department’s teaching program. “We hope that our donation can help someone else,” says Chuck. To learn about ways to give, email [email protected] or call (312) 996-6591. From left: Albert Barsky with his sons, Chuck and Scott 18 GIVING Honor Roll of Donors 2011—2012 † $100,000+ $2,500–4,999 $500–999 Dr. Daniel C. Alter Prof. Arnold R. Bodmer Arnold Bodmer & Family Trust Dr. David J. Fuerst Glaucoma Foundation, Inc. Dr. Paul A. Knepper and Dr. Zibute Zaparackas * Dr. David M. Lubeck ** Medical Eye Services, Ltd. Midwest Eye-Banks and Transplantation Center Dr. Phillip D. and Mrs. Vicki A. Alward ** Mr. Albert and Mrs. Doreen Barsky Dr. Felix Y. Chau Dr. Marc F. Greenberg and Ms. Susan H. Glatt Dr. Nancy A. Hamming Dr. Marcus and Mrs. Sue Muallem Dr. John H. Panton, FACS, SC Dr. Robert W. Panton Mrs. Jenifer Mason Robbins Dr. Kathleen M. Scarpulla Mr. Ira J. and Mrs. Beverly W. Schulman Dr. Thasarat S. Vajaranant Ms. Patricia S. Wager * Dr. Robert D. Wertz Dr. Douglas P. Williams Dr. Eirene Wong Research to Prevent Blindness, Inc. $50,000–99,999 American Health Assistance Foundation Dr. R. Mark and Mrs. Monica J. W. Hatfield * Hope for Vision Komarek-Hyde-McQueen Foundation Parent Petroleum $20,000–49,999 ABMRF/The Foundation for Alcohol Research Foundation Fighting Blindness Mr. Gary R. Janko * Dr. John H. Panton * Dr. Allen Putterman * Dr. Howard H. and Mrs. Tena Tessler * $10,000–19,999 Mr. Gerhard Cless * Cless Family Foundation Dr. Stephen A. Cullinan in honor of the UIC Illinois Eye Fund/Ophthalmology Cullinan/Falcon Foundation, Inc. Omega Surgery Centers, LLC Dr. Don M. Smart * Mr. Anthony Tworkoski $5,000–9,999 Arch W. Shaw Foundation Solna A. Braude ** Braude Foundation Mr. Bill Crown Edwin F. Schild Foundation Eye Bank Association Of America, Inc. Ms. Anne C. Haffner in honor of Dr. Paul Knepper ** Mrs. Diane K. Henry * Illinois Society for the Prevention of Blindness Dr. Sao Cheng Liu ** Dr. Sao Jang Liu * † For the fiscal year July 1, 2011 – June 30, 2012 $1,500–2,499 Batavia Lions Club Dr. Norbert M. Becker Mr. Julian L. and Mrs. Joan S. Berman * Fidelity Charitable Gift Fund Geneva Eye Clinic, Ltd. Katherine Knaphurst Trust (DEC) KLS Martin, LP Dr. Harris and Mrs. Jeanne Ripps Ms. Dorothy T. Tannenbaum $1,000–1,499 Dr. Alan J. and Mrs. Jennifer K. Axelrod Dr. Norman P. Blair Mr. Barry J. and Mrs. Barbara P. Carroll * The Carroll Foundation Dr. Richard M. Chavis Dr. Anne L. Coleman District 1-A Lions Clubs Dr. and Mrs. Deepak P. Edward * Dr. Debra A. Goldstein and Dr. David P. Cohen Dr. Sherwin Isenberg Dr. Lee M. Jampol Mr. Mark S. Kotz Kraff Eye Institute, Ltd. Dr. Jennifer I. Lim Dr. John J. and Mrs. Kathleen McGetrick ** Dr. Paul F. Nichols Dr. Brian A. and Mrs. Sonja R. Phillpotts Dr. George R. Reiss Dr. J. Patrick and Dr. Clarissa F. Rhode Dr. Donald R. Sanders Dr. William L. Schey ** Dr. Joanne Shen and Dr. Robert Ortega-Hamilton Dr. Veeral S. and Dr. Monica Johal Sheth Dr. George J. Wyhinny $250–499 Dr. Dimitri T. and Dr. Nathalie F. Azar * Mrs. Susan S. Donahue in memory of Dr. Elias Selinger Expert Optics, Inc. Dr. Jill A. Foster Dr. Frank R. Guastella Dr. John M. and Mrs. Sally Hattenhauer Dr. Sherwin Isenberg, Inc. Jules Stein Eye Institute Dr. Colman R. Kraff Dr. Manus C. Kraff Dr. Cheryl Kraff-Cooper Dr. Miriam T. Schteingart Light Dr. Frank I. and Mrs. Katherine Mendelblatt Mr. David W. Montross National Philanthropic Trust Ms. Lynn Orschel Dr. Ashok R. Penmatcha Mr. James T. Reid in honor of Dr. William Miele Up to $250 Dr. Prasant and Dr. Harvinder K. S. Atluri Dr. Amparo Barrido Mr. Charles L. Barsky Mr. Gregory B. Beggs Dr. Abdhish R. Bhavsar Mr. John J. and Mrs. Phyllis A. Bierdz Prof. L. Vaughn Blankenship Mr. Karney Boyajian Mrs. Andrea Bromberg One Vision 2012 19 Mrs. Marie J. Bugajski Dr. Michael E. Carroll Dr. Teresa C. Chen Chicago Cornea Consultants, Ltd. Mr. Christopher B. Cohen Mr. L. Park and Mrs. Sharlene M. Davis Discover Financial Services matching gift on behalf of Mr. Charles Barsky DuPage Ophthalmology Encompass Group, LLC Dr. Randy J. Epstein Dr. Victor F. Feldman Mr. Marc J. and Mrs. Geri Lynn Feldstein in honor of Dr. Stephen M. Litinsky Dr. Anthony G. Finder Mr. Dan and Mrs. Linda Fowler Dr. Joseph B. Garber Dr. Carl Garfinkle Miss Elden Genitis Ms. Anita S. Gerber Dr. Glenn S. Goldsher Mrs. Sylvia E. Greenberg Ms. Jacquelyn M. Guerra Dr. Balaji K. Gupta Dr. Margaret A. Halle Dr. David S. Hillman Mr. Richard A. and Mrs. Mary E. Howell Dr. Donald S. Jacobs Dr. Jeremy D. Keenan Ms. Kate T. Kestnbaum * Mrs. Patricia A. Konn Dr. Charlton Rex and Mrs. Janet M. Latta Mrs. Ale B. Lelis Mrs. Patricia M. Livingston Dr. Paul Arthur Mahlberg Dr. David I. and Mrs. Michele N. Malitz Ms. Helorna N. McFall Dr. Timothy T. and Mrs. Kay McMahon Dr. Irwin Menachof (DEC) Dr. Audrey C. Mok Mrs. Mildred R. Monsen Dr. Dorothy M. Moore and Mr. Garry J. Cap Dr. Paul K. and Mrs. Ruth Morimoto ** Mr. Gerald M. and Mrs. Barbara P. Newman Mr. Richard Palandech Mr. William D. Perkins Mrs. Sally L. Pope * Dr. Jose S. Pulido and Dr. Colleen A. Howe * Mr. Anthony L. Rainaldi Mr. James E. Rathmann Mr. Bernard B. Rinella Dr. David S. Robbin Mr. Marvin Rogan in memory of Dr. Laura E. Lehtinen-Rogan Dr. Alfred A. Rosenbloom Jr. Mr. David G. Rosenfeld Mr. Warner A. Rosenthal Mr. LeRoy and Mrs. Albina Schalansky Mrs. Gloria B. Schall Mr. Gary E. and Mrs. Nancy Q. Scheuermann in honor of Ms. Ellen M. Nichols Mr. Richard L. Schultz Mr. Leonard H. Solomon Ms. Barbara S. Spielman Dr. Alan V. Spigelman Dr. John B. Thompson Dr. Arnold Tobin Mr. Larry R. Tompkins UBS matching gift on behalf of United Way of Central New Mexico Samuel J. Vainisi DVM Mrs. Helen Vavrinchik Wells Fargo Foundation matching gift on behalf of Willow Springs Lioness Club Dr. George J. Witteman Mr. Michael J. and Mrs. Kathleen A. Worrall Dr. Terri L. Young Mr. Tony Zamora * President’s Council ** Chancellor’s Circle Illinois Eye Fund Board OFFICERS Dimitri Azar, MD, MBA CHAIR Samuel J. Cascio, DDS VICE PRESIDENT Julian L. Berman TREASURER Irene T. Schoenberg SECRETARY MEMBERS Barry J. Carroll Gerald Fishman, MD William Jackson Jones, DDS Steven P. Koenig, MD Barry Malkin Frank I. Mendelblatt, MD Marilyn T. Miller, MD Steven B. Ross Georgia Roulo Sriram Sonty, MD Van C. Stone Joel Sugar, MD Patricia Wager Jacob Wilensky, MD Emeritus Diane Kraft Henry Dr. Harris Ripps, DSc EX-OFFICIO Julie Daraska ADVANCEMENT David J. Eaton 20 Endowment Activity ENDOWMENT ACTIVITY REPORT Endowed gifts support valuable academic activity in the Department of Ophthalmology & Visual Sciences. We are proud to highlight just a few of the achievements of our endowed faculty and important endowed programs from the 2011–12 academic year. Endowed Lectures Morton F. Goldberg, MD, Endowed Lecture “The Demise of the Disc Margin and Cup to Disc Ratio in Glaucoma” Claude F. Burgoyne, MD Oregon Health and Sciences University Delivered June 29, 2012, at the 36th Annual Alumni / Resident Day Four Fathers Lecture “Manpower Needs in Ophthalmology” Joel Sugar, MD Illinois Eye and Ear Infirmary at UIC Delivered June 29, 2012, at the 36th Annual Alumni / Resident Day Jose S. Pulido, MD, Endowed Lecture “The Evolution of Surgery for Keratoconus” Mark J. Mannis, MD UC Davis Eye Center Delivered June 29, 2012, at the 36th Annual Alumni / Resident Day Samuel F. Schoenberg, MD, Memorial Lecture “Unlocking Mysteries in Measurements of the Retinal Nerve Fiber Layer” David S. Greenfield, MD Bascom Palmer Eye Institute Delivered May 16, 2012, at the Annual Glaucoma Symposium Jacob T. Wilensky, MD Lecture “Imaging in Glaucoma” Teresa C. Chen, MD Massachusetts Eye & Ear Infirmary Delivered May 16, 2012, at the Annual Glaucoma Symposium Gerhard Cless Endowed Lecture “Defining and Describing New Medical Retina Diseases such as the White Dot Syndromes” Lee Jampol, MD Northwestern Feinberg School of Medicine Delivered March 30, 2012, at the 5th Annual Retina Symposium Timothy McMahon, OD, Endowed Lecture "Opportunity for Impact: Therapeutic Lenses and Ocular Graft-vs-Host Disease” Deborah S. Jacobs, MD Massachusetts Eye & Ear Infirmary Delivered April 22, 2011 Marvin D. Henry, MD, Memorial Lecture “Pediatric Neuro-Ophthalmology” Grant T. Liu, MD University of Pennsylvania School of Medicine Delivered October 14, 2011, at the 2nd Biennial Neuro-Ophthalmology Symposium Eugene R. Folk, MD, Memorial Lecture “Phylogeny of Eye Movements and the Extraocular Muscles” Steven M. Archer, MD W.K. Kellogg Eye Center, University of Michigan Delivered September 16, 2011, at the Pediatric Ophthalmology Meeting Dr. Rohit Varma, Dean Dimitri Azar and Dr. Joel Sugar commend Dr. Sandeep Jain and Dr. Ali Djalilian on their promotion to Associate Professors. One Vision 2012 21 Endowed Chairs Endowed Professors Marion Schenk Esq. Professor of Ophthalmology Deepak Shukla, PhD Director, Ocular Virology Laboratory Two R21 grants submitted by Dr. Shukla to the National Eye Institute — Role of Optineurin in Ocular Herpes Infection and Entry Based Inhibition of Ocular HSV-1 Infection — were awarded at the end of 2012. He was invited as a keynote speaker to the annual meeting of the Indian Association of Medical Microbiologists in Varanasi, India. B.A. Field Chair of Ophthalmic Research Dimitri Azar, MD, MBA Professor of Ophthalmology and Dean, College of Medicine Morton F. Goldberg, MD, FAcs, Professor of Ophthalmology Mahnaz Shahidi, PhD Director, Applied Physics Laboratory National Eye Institute review of Dr. Shahidi’s competitive renewal application for her R01 research grant Noninvasive Imaging of Chorio-Retinal Oxygen Tension (R01EY017918) received a third percentile rank and is expected to be renewed through 2017. Dr. Shahidi was selected to serve on the NEI grant review study section, Diseases and Pathophysiology of the Visual System. Searls-Schenk Professor of Ophthalmology David Pepperberg, PhD Director, Photoreceptor Research Laboratory Illinois Lions / Charles I. Young Chair of Ophthalmology Rohit Varma, MD, MPH Professor of Ophthalmology and Department Chair * A paper recently published in Nature Communications by Dr. Pepperberg and his colleagues reports a milestone advance in their research to develop a new type of molecular therapy for age-related macular degeneration and related photoreceptor degenerative diseases. Their work involves the creation of novel light-sensitive chemical compounds that can interface with inner retinal nerve cells to “bypass” dysfunctional rod and cone photoreceptors in the diseased retina. Joel Sugar, MD, Endowed Professor of Ophthalmology Joel Sugar, MD Professor of Ophthalmology, Cornea Service In addition to serving as Interim Department Head in 2012, Dr. Sugar continued seeing patients and participated in the Cornea Donor study and the Fuchs Corneal Endothelial Dystrophy Study. He was awarded the Castroviejo Medal by the Cornea Society for “outstanding contributions to Ophthalmology in the field of cornea and anterior segment of the eye.” Jacob Wilensky, MD, Endowed Professor of Ophthalmology Jacob Wilensky, MD, Professor of Ophthalmology, Glaucoma Service Marion Schenk Esq. Chair of Ophthalmology Jennifer I. Lim, MD Professor of Ophthalmology and Director, Retina Service Dr. Jacob Wilensky served as the 47th C.S. O’Brien Professor at Tulane University Department of Ophthalmology, and delivered the lecture, “What have we learned from clinical trials in glaucoma?” at their Alumni Day, June 8 – 9, 2012. Dr. Wilensky earned his BA, MD, and completed his Ophthalmology Residency at Tulane. *Pending UIC Board of Trustees approval 22 FACULTY FACULTY Chair & Vice Chairs Professors Rohit Varma, MD, MPH Illinois Lions/Charles I. Young Chair of Ophthalmology* Professor of Ophthalmology and Department Chair Kenneth Alexander, PhD Professor Emeritus Joel Sugar, MD Joel Sugar, MD, Endowed Professor of Ophthalmology Vice Chair for Clinical Operations Dimitri Azar, MD, MBA Dean, College of Medicine B. A. Field Endowed Chair of Ophthalmologic Research Professor of Ophthalmology Jennifer Lim, MD Marion Schenk Esq., Chair of Ophthalmology Director, Retina Service Professor of Ophthalmology Irene Maumenee, MD Research Professor of Ophthalmology Director, Ocular Genetics Laboratory Harris Ripps, PhD, DSc Professor Emeritus Howard Tessler, MD Professor Emeritus Jacob Wilensky, MD Professor of Ophthalmology William Mieler, MD Professor of Ophthalmology Vice Chair for Education Director, Ocular Oncology Clinic Mahnaz Shahidi, PhD Morton F. Goldberg, MD, Professor of Ophthalmology Vice Chair for Research Director, Applied Physics Laboratory Norman Blair, MD Professor of Ophthalmology Director, Retinal Circulation and Metabolism Laboratory Gerald Fishman, MD Professor Emeritus Nalin Kumar, DPhil Professor of Ophthalmology Timothy McMahon, OD Professor of Ophthalmology Marilyn Miller, MD Professor of Ophthalmology Associate Professors David Pepperberg, PhD Searls-Schenk Professor of Ophthalmology Director, Photoreceptor Research Laboratory Allen Putterman, MD Professor of Ophthalmology *Pending UIC Board of Trustees approval Beatrice Yue, PhD Thanis A. Field Professor of Ophthalmology Director, Ocular Cell Biology Laboratory Nathalie Azar, MD Associate Professor of Clinical Ophthalmology Director, Pediatric Ophthalmology and Adult Strabismus One Vision 2012 23 Assistant Professors Dingcai Cao, PhD Associate Professor of Ophthalmology Ali Djalilian, MD Associate Professor of Ophthalmology Director, Stem Cell Research Laboratory Director, Medical Student Education in Ophthalmology Deepak Shukla, PhD Marion Schenk Esq. Professor of Ophthalmology Associate Professor of Microbiology and Immunology Director, Ocular Virology Laboratory Javaneh Abbasian, MD Assistant Professor of Ophthalmology Amjad Ahmad, MD Clinical Assistant Professor of Ophthalmology Joan Stelmack, OD Clinical Associate Professor of Ophthalmology Director, Low Vision Service Felix Chau, MD Assistant Professor of Ophthalmology Director, Retinal Bioengineering Laboratory Soledad Cortina, MD Assistant Professor of Ophthalmology Director, Comprehensive Ophthalmology Faculty Practice and General Eye Clinic Ahmad Aref, MD Assistant Professor of Ophthalmology James Goodwin, MD Associate Professor of Ophthalmology Director, Neuro-Ophthalmology Service Kimberlee Curnyn, MD Clinical Assistant Professor of Ophthalmology Benjamin Ticho, MD Clinical Assistant Professor of Ophthalmology Genie Bang, MD Assistant Professor of Ophthalmology Sandeep Jain, MD Associate Professor of Ophthalmology Director, Corneal Neurobiology Laboratory Jose de la Cruz, MD Assistant Professor of Ophthalmology Director, Millennium Park Eye Center Elmer Tu, MD Associate Professor of Clinical Ophthalmology Director, Cornea Service Jin-Hong Chang, PhD Research Assistant Professor of Ophthalmology Director, Angiogenesis Research Laboratory Charlotte Joslin, OD, PhD Associate Professor of Ophthalmology Director, Contact Lens Service Anthony Finder, MD Clinical Assistant Professor of Ophthalmology Marlos Viana, PhD Associate Professor of Biostatistics in Ophthalmology Associate Professor, College of Pharmacy Qing Chang, MD, PhD Research Assistant Professor of Ophthalmology Retinal Chemical Genomics Laboratory Paul Knepper, MD, PhD Research Scientist Robert FitzGerald, MD Clinical Assistant Professor of Ophthalmology 24 FACULTY Clinical Volunteer Faculty Molly Gilbert, MD Clinical Assistant Professor of Ophthalmology Director, Resident Education, James A. Lovell Federal Health Care Center Michael Grassi, MD Research Assistant Professor of Ophthalmology Director, Retinal Chemical Genomics Laboratory Alexander Khammar, MD Clinical Assistant Professor of Ophthalmology Charles Kinnaird, OD Clinical Assistant Professor of Ophthalmology Heather Moss, MD, PhD Assistant Professor of Ophthalmology Director, Neuro-Ophthalmology Research Program Pete Setabutr, MD Assistant Professor of Ophthalmology Director, Oculoplastic & Reconstructive Surgery Service Yannek Leiderman, MD, PhD Assistant Professor of Ophthalmology Director, Retinal Bank Laboratory Ellen Shorter, OD Assistant Professor of Ophthalmology Director, PROSE Clinic Anil Gulati, MD Clinical Assistant Professor of Ophthalmology Kyu Yeon Han, PhD Research Assistant Professor of Ophthalmology Metalloproteinases Research Laboratory David Hillman, MD Clinical Assistant Professor of Ophthalmology Iris Kassem, MD, PhD Assistant Professor of Clinical Ophthalmology Amy Lin, MD Assistant Professor of Pathology Assistant Professor of Ophthalmology Director, Ophthalmic Pathology Laboratory Mark Lunde, MD Clinical Assistant Professor of Ophthalmology Director of Resident Education, Jesse Brown Veterans Administration Jason McAnany, PhD Assistant Professor of Ophthalmology Aisha Traish, MD Assistant Professor of Ophthalmology Associate Director, Residency Program Director, Pediatric Cornea Clinic Larry Ulanski, MD Clinical Assistant Professor of Ophthalmology Thasarat Vajaranant, MD Assistant Professor of Ophthalmology Director, Glaucoma Service Daniel Alter, MD, PhD David Badawi, MD Adrienne Berman, MD Michael Blair, MD Rebekah Braslow, MD Victoria Butcko, OD Robert Egel, MD Steven Eiden, MD Gerald Fishman, MD Timothy Flood, MD Jon Geiser, MD Molly Gilbert, MD Daniel Greenberg, MD Bruce Kaplan, MD Spero Kinnas, MD Timothey Kisla, MD Sheridan Lam, MD Janet Lee, MD David Lubeck, MD Carol Menner, MD David Mittelman, MD Smajo Osmanovic, MD Anna Park, MD Kirk Packo, MD Rakhi Patil, MD Richard Quinones, MD Pervez Rasul, MD Alfred Rosenbloom, OD Kenneth Resnick, MD Michael Shapiro, MD Marcus Solomon, MD Sriram Sonty, MD Thomas Stelmack, OD Daniel Tepper, MD Charles Vygantas, MD Robert Weiss, MD Chloe Winterbotham, MD Joint Courtesy & Adjunct Faculty Anthony Peter Adamis, MD Eric C. Beyer, MD, PhD Robert Folberg, MD Craig Foster, PhD Ken-Ichiro Fukuchi, MD, PhD Richard A. Gemeinhart, PhD Jie Liang, PhD Robert Paul Malchow, PhD Asrar Malik, PhD Daniel Roberts, OD William H. Seiple, PhD Janet P. Szlyk, PhD Vaibhav Tiwari, PhD Kimani Toussaint, PhD Kazuo Tsubota, MD One Vision 2012 25 FACULTY PUBLICATIONS Illinois Eye and Ear Infirmary UIC Department of Ophthalmology & Visual Sciences Journal Articles 07.01.2011–06.30.2012 syndrome. Am J Med Genet A. 2011 Jul;155A(7):1668-72. doi: 10.1002/ajmg.a.34071. Aakalu VK, Putterman AM. Fat repositioning in lower lid blepharoplasty: the role of titrated excision. Ophthal Plast Reconstr Surg. 2011 Nov;27(6):462. Bakhtiari P, Chan C,Welder JD, de la Cruz J, Holland EJ, Djalilian AR. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia. Am J Ophthalmol. 2012 May;153(5):967971.e2. Epub 2012 Jan 21. Aakalu VK, Setabutr P. Current ptosis management: a national survey of ASOPRS members. Ophthal Plast Reconstr Surg. 2011 Jul-Aug;27(4):270-6. Abbasian J, Martin TM, Patel S, Tessler HH, Goldstein DA. Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease. Am J Ophthalmol. 2012 Jul;154(1):72-7. Epub 2012 Mar 30. Ali MM, Karasneh GA, Jarding MJ,Tiwari V, Shukla D. A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells. J Virol. 2012 Jun;86(12):6434-43. Anastasakis A, Genead MA, McAnany JJ, Fishman GA. Evaluation of retinal nerve fiber layer thickness in patients with retinitis pigmentosa using spectral-domain optical coherence tomography. Retina. 2012 Feb;32(2):358-63. Aref AA. Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy. Curr Opin Ophthalmol. 2012 Mar;23(2):105-10. Aref AA, Gedde SJ, Budenz DL. Glaucoma drainage implant surgery. Dev Ophthalmol. 2012;50:37-47. Epub 2012 Apr 17. Review. Baker S, Booth C, Fillman C, Shapiro M, Blair MP, Hyland JC, Ala-Kokko L. A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler Bold: Regular Faculty Blair MP, Shapiro MJ, Hartnett ME. Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children. J AAPOS. 2012 Jun;16(3):234-7. Pediatric Eye Disease Investigator Group [Ticho BH, Khammar AJ], Bradfield YS, Melia BM, Repka MX, Kaminski BM, Davitt BV, Johnson DA, Kraker RT, Manny RE, Matta NS, Weise KK, Schloff S. Central corneal thickness in children. Arch Ophthalmol. 2011 Sep;129(9):1132-8. Borchert MS, Varma R, Cotter SA,Tarczy-Hornoch K, McKeanCowdin R, Lin JH,Wen G, Azen SP, Torres M, Tielsch JM, Friedman DS, Repka MX, Katz J, Ibironke J, Giordano L; Joint Writing Committee* for the Multi-Ethnic Pediatric Eye Disease Study and the Baltimore Pediatric Eye Disease Study Groups. Risk factors for hyperopia and myopia in preschool children: The MultiEthnic and Baltimore Pediatric Eye Disease Studies. Ophthalmology 2011;118(10):1966-1973. detection. J Opt Soc Am A Opt Image Sci Vis. 2012 Feb 1;29(2):A188-93. doi: 10.1364/ JOSAA.29.00A188. soft contact lens wearers from the Contact Lens Assessment in Youth (CLAY) study. Invest Ophthalmol Vis Sci. 2011 Aug 24;52(9):6690-6. Cao D, Lu YH. Chromatic discrimination: differential contributions from two adapting fields. J Opt Soc Am A Opt Image Sci Vis. 2012 Feb 1;29(2):A1-9. doi: 10.1364/ JOSAA.29.0000A1. Chabi A, Varma R, Tsai JC, Lupinacci R, Pigeon J, Baranak C, Noble L, Lines C, Ho,TW. Randomized clinical trial of the efficacy and safety of preservativefree Tafluprost and Timolol in patients with open-angle glaucoma or ocular hypertension, Am J Ophthalmol 2012;153(6):1187-1196. Cao D, Pokorny J, Grassi MA. Isolated mesopic rod and cone electroretinograms realized with a four-primary method. Doc Ophthalmol. 2011 Aug;123(1):29-41. doi: 10.1007/s10633-011-9279-9. Cao D, Zele AJ, Pokorny J, Lee DY, Messner LV, Diehl C, Ksiazek S. Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis. Invest Ophthalmol Vis Sci. 2011 Nov 17;52(12):8900-7. Caprioli J, Varma R. Intraocular pressure: modulation as treatment for glaucoma. Am J Ophthalmol 2011;152(3):340-344.e2. Chalmers RL,Wagner H, Mitchell GL, Lam DY, Kinoshita BT, Jansen ME, Richdale K, Sorbara L, McMahon TT. Age and other risk factors for corneal infiltrative and inflammatory events in young Bressler NM, Doan QV, Varma R, Lee PP, Suner IJ, Dolan C, Danese MD,Yu E,Tran I and Colman S. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: Non-Hispanic White population in the United States with age-related macular degeneration. Arch Ophthalmol 2011;129(6):709-717. Cao D, Lu YH. Lateral suppression of mesopic rod and cone flicker Red: Volunteer and Adjunct Faculty Blue: Residents and Fellows Chang JR, Koo E, Agrón E, Hallak J, Clemons T, Azar D, Sperduto RD, Ferris FL 3rd, Chew EY; AgeRelated Eye Disease Study Group. Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32. Ophthalmology. 2011 Nov;118(11):2113-9. Chang Q, Peter ME, Grassi MA. Fas ligand-fas signaling participates in light-induced apoptotic death in photoreceptor cells. Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3703-16. Chaudhary S, Namavari A,Yco L, Chang JH, Sonawane S, Khanolkar V, Sarkar J, Jain S. Neurotrophins and nerve regeneration-associated genes are expressed in the cornea 26 PUBLICATIONS after lamellar flap surgery. Cornea. 2012 Jun 5. [Epub ahead of print] Chen L, Xu G, Blair MP. Diagnostic and therapeutic challenges. Retina. 2011 Jul-Aug;31(7):1424-7. Chen PJ, Saati S, Varma R, Humayun MS, and Tai YC. Wireless intraocular pressure sensing using microfabricated minimally invasive flexible-coiled LC sensor implant. J of Microelectromechanical Systems 2010;19(4):721-34. Choudhury F, Varma R, Klein R, Azen SP, Mckean-Cowdin R and the Los Angeles Latino Eye Study Group. Risk factors for four-year incidence and progression of age related macular degeneration: The Los Angeles Latino Eye Study. Am J Ophthalmol 2011;152(3):385-95. Chow CC, Blair MP, Shapiro MJ. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep;129(9):1234-5. Chow CC, Genead MA, Anastasakis A, Chau FY, Fishman GA, Lim JI. Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. Am J Ophthalmol. 2011 Oct;152(4):704-711.e2. Epub 2011 Jul 2. Cortina MS, He J, Li N, Bazan NG, Bazan HE. Recovery of corneal sensitivity, calcitonin gene-related peptide-positive nerves, and increased wound healing induced by pigment epithelial-derived factor plus docosahexaenoic acid after experimental surgery. Arch Ophthalmol. 2012 Jan;130(1):76-83. Cortina MS, Vajaranant T, de la Cruz J. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol. 2011 Dec;152(6):1078-9; author reply 1079. Cotter SA, Varma R, TarczyHornoch K, McKean-Cowdin R, Lin J,Wen G, Wei J, Borchert M, Azen SP, Torres M, Tielsch JM, Friedman DS, Repka MX, Katz J, Ibironke J, Giordano L; The Joint Writing Committee* for the Multi-Ethnic Pediatric Eye Disease Study and the Baltimore Pediatric Eye Disease Study Groups. Risk factors associated with childhood strabismus: The Multi-Ethnic and the Baltimore Pediatric Eye Disease Studies. Ophthalmology 2011;118(11):2251-61. Cunningham ET Jr, Goldstein DA, Zierhut M. Uveitis treatment trials — a cross-study perspective. Ocul Immunol Inflamm. 2012 Apr;20(2):63-7. Czugala M, Karolak JA, Nowak DM, Polakowski P, Pitarque J, Molinari A, Rydzanicz M, Bejjani BA, Yue BY, Szaflik JP, Gajecka M. Novel mutation and three other sequence variants segregating with phenotype at keratoconus 13q32 susceptibility locus. Eur J Hum Genet. 2012 Apr;20(4):389-97. Dosa S, Castellanos K, Bacsa S, Gagyi E, Kovacs SK, Valyi-Nagy K, Shukla D, Dermody TS, ValyiNagy T. Chronic progressive deficits in neuron size, density and number in the trigeminal ganglia of mice latently infected with herpes simplex virus. Brain Pathol. 2011 Sep;21(5):583-93. Francis B, Varma R, Lai M,Vigen C, Winarko J, Nguyen B, and Azen SP. Population and high risk group screening for glaucoma: The Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 2011;52(3):6257-6264. Farooq AV, Shukla D. Herpes Simplex Epithelial and Stromal Keratitis: An Epidemiologic Update. Surv Ophthalmol. 2012 Apr 28. [Epub ahead of print] PubMed PMID: 22542912. Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT; Multicenter Uveitis Steroid Treatment-MUST Trial Research Group [Goldstein DA, Lim JI,Tessler HH]. Associations among visual acuity and vision- and healthrelated quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci. 2012 Mar 9;53(3):1169-76. Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD; Diabetic Retinopathy Clinical Research Network [Lim JI]. Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6168-73. Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK,Wong IG, Kempen JH; MUST Trial Research Group [Goldstein DA, Lim JI,Tessler HH]. Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocul Immunol Inflamm. 2011 Aug;19(4):267-74. Gao X, Marjoram P, MckeanCowdin R,Torres M, Gauderman W, and Varma R. Genotype imputation for Latinos using the HapMap and 1000 Genomes Project reference panels. Frontiers in Statistical Genetics and Methodology 2012: 2012;3:117. Gatto NM, Varma R, Torres M, Wong TY, Johnson PL, SegalGidan F, and Mack W. Retinal microvascular abnormalities and cognitive function in Latino Adults in Los Angeles. Ophthalmic Epidemiol 2012;19(3):127-136. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC, Tube Versus Trabeculectomy Study Group (Varma R). Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 2012; 153(5):804814.e1. Gedde SJ, Singh K, Schiffman JC, Feuer WJ; the Tube Versus Trabeculectomy Study Group (Varma R). The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice. Curr Opin Ophthal 2012; 23(2):118–126. Genead MA, McAnany JJ, Fishman GA. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina. 2012 Apr;32(4):826-33. Genead MA, Fishman GA, Rha J, Dubis AM, Bonci DM, Dubra A, Stone EM, Neitz M, Carroll J. Photoreceptor structure and function in patients with congenital achromatopsia. Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7298-308. Genead MA, Fishman GA. Efficacy of brinzolamide ophthalmic suspension 1% for treatment of a vitelliform macular lesion in a patient with desferrioxamine retinopathy. Ophthalmic Surg Lasers Imaging. 2011 Dec 8;42. Ghanem RC, Han KY, Rojas J, Ozturk O, Kim DJ, Jain S, Chang JH, Azar DT. Semaphorin 7A promotes angiogenesis in an experimental corneal neovascularization model. Curr Eye Res. 2011 Nov;36(11):989-96. Girkin CA, McGwin G Jr, Sinai MJ, Sekhar GC, Fingeret M, Wollstein G, Varma R, Greenfield D, Liebmann J, Araie M, Tomita G, Maeda N, Garway-Heath DF. Variation in optic nerve and macular structure with age and race with spectral-domain optical coherence tomography. Ophthalmology 2011;118(12):2403-8. One Vision 2012 27 Gowrisankaran S, Alexander KR. Stimulus chromatic properties affect period doubling in the human cone flicker ERG. Doc Ophthalmol. 2012 Aug;125(1):21-9. Gowrisankaran S, Anastasakis A, Fishman GA, Alexander KR. Structural and functional measures of inner retinal integrity following visual acuity improvement in a patient with hereditary motor and sensory neuropathy type VI. Ophthalmic Genet. 2011 Sep;32(3):188-92. Grassi MA, Tikhomirov A, Ramalingam S, Lee KE, Hosseini SM, Klein BE, Klein R, Lussier YA, Cox NJ, Nicolae DL. Replication analysis for severe diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2377-81. Grewal DS, Sehi M, Paauw JD, Greenfield DS; Advanced Imaging in Glaucoma Study Group (Varma R). Detection of progressive retinal nerve fiber layer thickness loss with optical coherence tomography using 4 criteria for functional progression. J Glaucoma 2012;21(4):214-20. Gussin HA, Khasawneh FT, Xie A, Feng F, Memic A, Qian H, Le Breton GC, Pepperberg DR. Subunit-specific polyclonal antibody targeting human 1 GABA(C) receptor. Exp Eye Res. 2011 Jul;93(1):59-64. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group [Blair NP, Goldstein DA, Grassi M, Lim JI, Mieler WF, Shapiro MJ, Ulanski LJ], Li J. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011 Dec;118(12):2453-60. Han KY, Fahd DC,Tshionyi M, Allemann N, Jain S, Chang JH, Azar DT. MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett. 2012 Jun 4. [Epub ahead of print] PubMed PMID: 22670674. Han KY, Azar DT, Sabri A, Lee H, Jain S, Lee BS, Chang JH. Characterization of the interaction between endostatin short peptide and VEGF receptor 3. Protein Pept Lett. 2012 Apr 16. [Epub ahead of print] PubMed PMID: 22512651. Bold: Regular Faculty Harel S, Tu EY, Weisberg S, Esquilin M, Chambers SM, Liu B, Carson CT, Studer L, Reizis B, Tomishima MJ. ZFX Controls the self-renewal of human embryonic stem cells. PLoS One. 2012;7(8):e42302. Epub 2012 Aug 3. Hernandez C, LePoole C, Tessler HH.Vogt-Koyanagi-Harada syndrome in a six-year-old Hispanic boy. Pediatr Dermatol. 2012 MarApr;29(2):191-4. He M, Abdou A, Naidoo KS, Sapkota YD,Thulasiraj RD, Varma R, Zhao J and Ellwein LB. Prevalence and correction of near vision impairment at seven sites in China, India, Nepal, Niger, South Africa, and the United States. Am J Ophthalmol 2012;154(1):107-116.e1. Hoang Q, Chau FY, Shahidi M, Lim JI. In reply to “Spectral domain optical coherence tomography for assessment of sickle cell patients.” Am J Ophthalmol. 2011;152(6):1074; author reply 1074-5. Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group [Lim JI]. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. Am J Ophthalmol. 2011 Oct;152(4):628637.e1. Hou JH, de la Cruz J, Djalilian AR. Outcomes of Boston Keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft. Cornea. 2012 Jan 10. [Epub ahead of print] PubMed PMID: 22236785. Hsu M, Tu E, Bouchard C. Confocal microscopy of contact lens keratitis presenting as central toxic keratopathy. Eye Contact Lens. 2011 Nov;37(6):377-80. Hu J, Chow CC, Kiernan DF, Garcia-Valenzuela E, Mafee MF, Blair MP, Shapiro MJ. Peripheral retinal nonperfusion associated with optic nerve hypoplasia and lissencephaly. Arch Ophthalmol. 2012 Mar;130(3):398-400. Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R. Reactivation of retinopathy of prematurity after bevacizumab Red: Volunteer and Adjunct Faculty injection. Arch Ophthalmol. 2012 Apr 9. [Epub ahead of print] Huang D, Chopra V, Lu AT, Tan O, Francis B, Varma R and the Advanced Imaging for Glaucoma Study. Does optic nerve head size variation affect circumpapillary retinal nerve fiber layer thickness measurement by optical coherence tomography? Invest Ophthalmol Vis Sci.2012; 53(8):4990-7. Hwang JC, Konduru R, Zhang X,Tan O, Francis BA, Varma R, Sehi M, Greenfield DS, Sadda SR, and Huang D. Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci 2012;53(6):3020-6. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, Conlon TJ, Calcedo R, Pang JJ, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012 Jan;130(1):9-24. Jansen ME, Chalmers R, Mitchell GL, Kinoshita BT, Lam DY, McMahon TT, Richdale K, Sorbara L,Wagner H. Characterization of patients who report compliant and non-compliant overnight wear of soft contact lenses. Cont Lens Anterior Eye. 2011 Oct;34(5):229-35. Jiang X, Varma R, Wu S,Torres M, Azen SP, Francis BF, Chopra V, and Nguyen BB for the Los Angeles Latino Eye Study Group. Baseline risk factors that predict the development of open-angle glaucoma in a population: The Los Angeles Latino Eye Study. Ophthalmology 2012: Available online 12 July 2012. Kang JJ, de la Cruz J, Cortina MS.Visual Outcomes of Boston Keratoprosthesis implantation as the primary penetrating corneal procedure. Cornea. 2012 Feb 23. [Epub ahead of print] Karasneh GA, Shukla D. Herpes simplex virus infects most cell types in vitro: clues to its success.Virol J. 2011 Oct 26;8:481. Review. Karasneh GA, Ali M, Shukla D. An important role for syndecan-1 in Blue: Residents and Fellows herpes simplex virus type-1 induced cell-to-cell fusion and virus spread. PLoS One. 2011;6(9):e25252. Epub 2011 Sep 21. Kiernan DF, Zelkha R, Hariprasad SM, Lim JI, Blair MP, Mieler WF. En face spectral-domain optical coherence tomography outer retinal analysis and relation to visual acuity. Retina. 2012 Jun;32(6):1077-86. Kiernan DF, Shah RJ, Hariprasad SM, Grassi MA, Small KW, Kiernan JP, Mieler WF.Thirty-Year followup of an African American family with macular dystrophy of the retina, locus 1 (North Carolina macular dystrophy). Ophthalmology. 2011 Jul;118(7):1435-43. Kopplin LJ, Przepyszny K, Schmotzer B, Rudo K, Babineau DC, Patel SV,Verdier DD, Jurkunas U, Iyengar SK, Lass JH; Fuchs’ Endothelial Corneal Dystrophy Genetics Multi Center Study Group [Sugar J, Tu E]. Relationship of Fuchs endothelial corneal dystrophy severity to central corneal thickness. Arch Ophthalmol. 2012 Apr;130(4):433-9. Krakauer M, Aakalu VK, Davis PL, Ahmad AZ. Silicone spacer repair of medial rectus after iatrogenic orbit fracture. Ophthal Plast Reconstr Surg. 2012 May;28(3):e57-8. Krakauer M, Welder JD, Pandya HK, Nassiri N, Djalilian AR. Adverse effects of systemic immunosuppression in keratolimbal allograft. J Ophthalmol. 2012;2012:576712. Le-Nguyen XT, Lee TK, Do DV, Sepah YJ, Nguyen QD, Rao NA, Vasconcelos-Santos DV, Goldstein DA. Diagnostic and therapeutic challenges. Retina. 2011 Sep;31(8):1732-9. Li L, Cheung CY, Liu Y, Chia A, Selvaraj P, Lin X, Chan Y, Varma R, Mitchell P, Wong T and Saw S. Influence of blood pressure on retinal vascular caliber in young children. Ophthalmology 2011;118(7):1459-65. Li SY, Gilbert ME, Chavis PS. Bilateral optic disk swelling plus. Surv Ophthalmol. 2012 MarApr;57(2):195-9. Epub 2011 May 31. Li SY, Birnbaum AD, Tessler HH, Goldstein DA. Posterior syphilitic uveitis: clinical characteristics, co-infection with HIV, response to 28 PUBLICATIONS treatment. Jpn J Ophthalmol. 2011 Sep;55(5):486-94. Lim JI, Fung AE,Wieland M, Hung D, Wong V. Sustained- release intravitreal liquid drug delivery using triamcinolone acetonide for cystoid macular edema in retinal vein occlusion. Ophthalmology. 2011 Jul;118(7):1416-22. Lim JI. Management of Retinal Vein Occlusion and Macular Edema: An Evidence-based Approach. Audio-Digest Ophthalmology Volume 50, Issue 19. Louttit MD, Kopplin LJ, Igo RP Jr, Fondran JR, Tagliaferri A, Bardenstein D, Aldave AJ, Croasdale CR, Price MO, Rosenwasser GO, Lass JH, Iyengar SK; Fuchs’ Endothelial Corneal Dystrophy Genetics Multi-Center Study Group [Sugar J, Tu E]. A multicenter study to map genes for Fuchs endothelial corneal dystrophy: baseline characteristics and heritability. Cornea. 2012 Jan;31(1):26-35. Mazhar K, Varma R, Choudhury F, McKean-Cowdin R, Shtir C, and Azen SP. Severity of diabetic retinopathy and healthrelated quality of life: LALES. Ophthalmology 2011;118(4):649-655. McAnany JJ, Alexander KR, Lim JI, Shahidi M. Object frequency characteristics of visual acuity. Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9534-8. McKean-Cowdin R, Varma R, Cotter SA,Tarczy-Hornoch K, Borchert MS, Lin JH,Wen G, Azen SP,Torres M,Tielsch JM, Friedman DS, Repka MX, Katz J, Ibironke J, Giordano L; Joint Writing Committee; Multi-Ethnic Pediatric Eye Disease Study and the Baltimore Pediatric Eye Disease Study Groups. Risk factors for astigmatism in preschool children: The MultiEthnic and Baltimore Pediatric Eye Disease Studies. Ophthalmology 2011;118(10):1974-1981. McLeod R, Boyer KM, Lee D, Mui E, Wroblewski K, Karrison T, Noble AG, Withers S, Swisher CN, Heydemann PT, Sautter M, Babiarz J, Rabiah P, Meier P, Grigg ME; Toxoplasmosis Study Group [Mieler WF]. Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis. 2012 Jun;54(11):1595-605. McMahon TT, Irving EL, Lee C. Accuracy and repeatability of self-measurement of interpupillary distance. Optom Vis Sci. 2012 Jun;89(6):901-7. Mieler WF, Kang-Mieler JJ. Something about Larry. Retina. 2012 Feb;32 Suppl 1:S27-8. Miller MT, Strömland KK. What can we learn from the thalidomide experience: an ophthalmologic perspective. Curr Opin Ophthalmol. 2011 Sep;22(5):356-64. Review. Mimura T, Chang JH, Kim TI, Onguchi T, Kojima T, Sakimoto T, Azar DT. MT1-MMP cleavage of the antiangiogenic proteoglycan decorin: role in corneal angiogenesis. Cornea. 2011 Oct;30 Suppl 1:S45-9. Retraction in: Cornea. 2012 Apr;31(4):467. Mishra YK, Adelung R, Röhl C, Shukla D, Spors F,Tiwari V. Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1. Antiviral Res. 2011 Nov;92(2):305-12. Moss HE, McCluskey L, Elman L, Hoskins K, Talman L, Grossman M, Balcer LJ, Galetta SL, Liu GT. Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci. 2012 Mar 15;314(1-2):97-101. Moss HE, Liu GT. Acute optic neuropathy associated with an intracranial mass in a patient with POEMS syndrome. J Neuroophthalmol. 2012 Mar;32(1):45-7. Moss HE, Mejico LJ, de la Roza G, Coyne TM, Galetta SL, Liu GT. IgG4-related inflammatory pseudotumor of the central nervous system responsive to mycophenolate mofetil. J Neurol Sci. 2012 Jul 15;318(1-2):31-5. Mousavi SJ, Nassiri N, Masoumi N, Nassiri N, Majdi-N M, Farzaneh S, Djalilian AR, Peyman GA. Finite element analysis of blunt foreign body impact on the cornea after PRK and LASIK. J Refract Surg. 2012 Jan;28(1):59-64. Movahedan A, Djalilian AR. Cataract surgery in the face of ocular surface disease. Curr Opin Ophthalmol. 2012 Jan;23(1):68-72. Review. Multi-Ethnic Pediatric Eye Disease Study Group (Varma R). Prevalence of astigmatism in 6 to 72 months old African American and Hispanic children: The MultiEthnic Pediatric Eye Disease Study. Ophthalmology 2011;118(2): 284-293. Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R; CIGTS Study Group. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011;118(9):1766-73. Namavari A, Chaudhary S, Chang JH,Yco L, Sonawane S, Khanolkar V, Yue BY, Sarkar J, Jain S. Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves. Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):732-40. Namavari A, Chaudhary S, Ozturk O, Chang JH,Yco L, Sonawane S, Katam N, Khanolkar V, Hallak J, Sarkar J, Jain S. Semaphorin 7a links nerve regeneration and inflammation in the cornea. Invest Ophthalmol Vis Sci. 2012 Jul 9;53(8):4575-85. Namavari A, Chaudhary S, Sarkar J, Yco L, Patel K, Han KY, Yue BY, Chang JH, Jain S. In vivo serial imaging of regenerating corneal nerves after surgical transection in transgenic thy1-YFP mice. Invest Ophthalmol Vis Sci. 2011 Oct 11;52(11):8025-32. Nassiri N, Nassiri N, Majdi M, Mehrjardi HZ, Shakiba Y, Haghnegahdar M, Heidari AB, Djalilian AR, Mirahmadian M. Erythropoietin levels in aqueous humor of patients with glaucoma. Mol Vis. 2012;18:1991-5. Nassiri N, Nassiri N, Majdi-N M, Salehi M, Panahi N, Djalilian AR, Peyman GA. Corneal endothelial cell changes after Ahmed valve and Molteno glaucoma implants. Ophthalmic Surg Lasers Imaging. 2011 Sep-Oct;42(5):394-9. Oldenburg CE, Acharya NR, Tu EY, Zegans ME, Mannis MJ, Gaynor BD,Whitcher JP, Lietman TM, Keenan JD. Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea. 2011 Dec;30(12):1363-8. Oltra EZ, Morris C, Birnbaum AD, Tessler HH, Goldstein DA. Chronic anterior uveitis in common variable immunodeficiency. Ocul Immunol Inflamm. 2011 Dec;19(6):448-9. Pai A, Rose KA, Samarawickrama C, Fotedar R, Burlutsky G, Varma R, and Mitchell P. Testability of refraction, stereopsis, and other ocular measures in preschool children: The Sydney Paediatric Eye Disease Study. J of American Association for Pediatric Ophthalmology and Strabismus 2012; 16(2):185-92. Pai AS, Rose KA, Leone JF, Sharbini S, Burlutsky G, Varma R, Wong TY and Mitchell P. Amblyopia Prevalence and risk factors in Australian preschool children. Ophthalmology 2012;119(1):138-44. Pai AS,Wang JJ, Samarawickrama C, Burlutsky G, Rose KA, Varma R, Wong TY and Mitchell P. Prevalence and risk factors for visual impairment in preschool children: The Sydney Paediatric Eye Disease Study. Ophthalmology 2011;118(8):1495-1500. Pai AS, Wang JJ, Samarawickrama C, Burlutsky G, Rose KA, Varma R, Wong TY, and Mitchell P. Prevalence and risk factors for visual impairment in preschool children: The Sydney Paediatric Eye Disease Study. Ophthalmology 2011;118(8):1495-500. Pan Y and Varma R. Natural history of glaucoma. Indian J Ophthalmology 2011:59 Suppl 1:S19-23. Patel KH, Birnbaum AD, Tessler HH, Goldstein DA. Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center. Retina. 2011 Jul-Aug;31(7):1387-91. Patel RD, Blair MP, Shapiro MJ, Lichtenstein SJ. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun;130(6):801-2. Patino CM, Varma R, Azen SP, Conti DV, Nichol MB, McKeanCowdin R, and the Los Angeles Latino Eye Study Group. The impact of change in visual field on health- related quality of life: The Los Angeles Latino Eye Study. Ophthalmology 2011;118:1310-1317. Patty L, Wu C, Torres M, Azen S and Varma R. Validity of selfreported eye disease and treatment One Vision 2012 29 in a population based study: The Los Angeles Latino Eye Study. Ophthalmology 2012: 119(9):1725-30. Pham M, Chow CC, Badawi D, Tu EY. Use of infliximab in the treatment of peripheral ulcerative keratitis in Crohn disease. Am J Ophthalmol. 2011 Aug;152(2):183-188.e2. Latino Eye Study. Ophthalmology 2012;119(3):547-54. A, Ozturk O, Chang JH, Yco L, Sonawane S, Khanolkar V, Hallak J, Jain S. Corneal neurotoxicity due to topical benzalkonium chloride. Invest Ophthalmol Vis Sci. 2012 Apr 6;53(4):1792-802. Rine RM, Roberts D, Corbin BA, McKean-Cowdin R, Varma R, Beaumont J, Slotkin J and Schubert MC. New portable tool to screen vestibular and visual function – National Institutes of Health Toolbox Initiative. JRRD 2012; 49(2):209-220. edema. Arch Ophthalmol. 2012 Apr;130(4):470-9. Taneri S, Oehler S, Azar DT. Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer. J Refract Surg. 2011 Sep;27(9):678-85. Roberts DK,Yang Y, Lukic AS, Wilensky JT, Wernick MN. Quantification of pupil parameters in diseased and normal eyes with near infrared iris transillumination imaging. Ophthalmic Surg Lasers Imaging. 2012 May- Jun;43(3):196-204. Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard JD, Burke A, Srivastava SK, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group [Goldstein DA, Lim JI,Tessler HH]. Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm. 2012 Apr;20(2):104-12. Putterman AM. Consecutive conjunctivodacryocystorhinostomy instrumentation. Ophthal Plast Reconstr Surg. 2011 SepOct;27(5):396-7. Saidel MA, Paik JY, Garcia C, Russo P, Cao D, Bouchard C. Prevalence of sleep apnea syndrome and high-risk characteristics among keratoconus patients. Cornea. 2012 Jun;31(6):600-3. Shafiq MA, Gemeinhart RA, Yue BY, Djalilian AR. Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng Part C Methods. 2012 May;18(5):340-8. Putterman AM. Accidentally injected formaldehyde during cosmetic blepharoplasty. Plast Reconstr Surg. 2011 Aug;128(2):587; author reply 587. Salameh S, Sheth U, Shukla D. Early events in herpes simplex virus lifecycle with implications for an infection of lifetime. Open Virol J. 2012;6:1-6. Epub 2012 Jan 19. Shah M, Kapur R, Raja S, Blair MP. Transconjunctival 20-gauge vitrectomy outcomes. Ophthalmic Surg Lasers Imaging. 2011 JulAug;42(4):278-83. Tarczy-Hornoch K, Varma R, Cotter SA, McKean-Cowdin R, Lin JH, Borchert MS, Torres M, Wen G, Azen SP, Tielsch JM, Friedman DS, Repka MX, Katz J, Ibironke J, Giordano L; Joint Writing Committee for the Multi-Ethnic Pediatric Eye Disease Study and the Baltimore Pediatric Eye Disease Study Groups. Risk factors for decreased visual activity in preschool children: the MultiEthnic and Baltimore Pediatric Eye Disease Studies. Ophthalmology 2011;118(11):2262-73. Richter GM, Choudhury F, Torres M, Azen SP, Varma R for the Los Angeles Latino Eye Study Group. Risk factors for incident cortical, nuclear, posterior subcapsular, and mixed lens opacities: The Los Angeles Latino Eye Study. Ophthalmology 2012;119(10):2040–2047. Saleh OA, Birnbaum AD, Tessler HH, Goldstein DA. Behçet uveitis in the American Midwest. Ocul Immunol Inflamm. 2012 Feb;20(1):12-7. Erratum in: Ocul Immunol Inflamm. 2012 Apr;20(2):149. Shukla SY, Kiernan D, Lim JI, Role of Anti-VEGF therapies in neovascular AMD: what the clinical trials tell us. International Journal of Medical and Biological Frontiers. 2010. 17(11). Teng PY, Blair NP, Wanek J, Shahidi M. Oxygen tension and gradient measurements in the retinal microvasculature of rats. Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):361-7. Singa RM, Aakalu VK, Putterman AM, Epstein GA. Lower- eyelid tarsal ectropion repair with the Putterman ptosis clamp for lowereyelid conjunctival Mueller’s muscle resection and lateral tendon tuck. Ophthal Plast Reconstr Surg. 2012 May;28(3):224-7. Tiwari V, Shukla D. Nonprofessional phagocytosis can facilitate herpes virus entry into ocular cells. Clin Dev Immunol. 2012;2012:651691. Epub 2012 Mar 15. Putterman AM. Müllerectomy procedure. Plast Reconstr Surg. 2012 Feb;129(2):356e; author reply 356e-357e. Putterman AM. Deep and superficial eyelid fascia. Plast Reconstr Surg. 2012 Apr;129(4):721e3e; author reply 723e. Richter GM, Torres M, Choudhury F, Azen SP, Varma R for The Los Angeles Latino Eye Study. Risk factors for cortical, nuclear, posterior subcapsular, and mixed lens opacities: The Los Angeles Saraiya NV, Patel SS, Goldstein DA. A report of high intraocular pressure with the dexamethasone intravitreal implant. Arch Ophthalmol. 2011 Dec;129(12):16389; author reply 1639-40. Sarkar J, Chaudhary S, Namavari Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group [Lim JI]. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. Sugar J, Macsai MS. What causes keratoconus? Cornea. 2012 Jun;31(6):716-9. Review. Sun JK, Qin H, Aiello LP, Melia M, Beck RW, Andreoli CM, Edwards PA, Glassman AR, Pavlica MR; Diabetic Retinopathy Clinical Research Network [Lim JI]. Evaluation of visual acuity measurements after autorefraction vs manual refraction in eyes with and without diabetic macular Bold: Regular Faculty Red: Volunteer and Adjunct Faculty Blue: Residents and Fellows Taneri S, Oehler S, Koch J, Azar DT. Effect of repositioning or discarding the epithelial flap in laserassisted subepithelial keratectomy and epithelial laser in situ keratomileusis. J Cataract Refract Surg. 2011 Oct;37(10):1832-46. Tiwari V, Liu J, Valyi-Nagy T, Shukla D. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J Biol Chem. 2011 Jul 15;286(28):25406-15. Epub 2011 May 19. Tshionyi M, Shay E, Lunde E, Lin A, Han KY, Jain S, Chang JH, Azar DT. Hemangiogenesis and lymphangiogenesis in corneal pathology. Cornea. 2012 Jan;31(1):74-80. Tu EY, Joslin CE. Microsporidia and Acanthamoeba: the role of emerging corneal pathogens. Eye (Lond). 2012 Feb;26(2):222-7. Tu EY, Pham M, Chow CC, Badawi D. Reply. Am J Ophthalmol. 2012 Feb;153(2):384-5. Vajaranant TS, Wu S, Torres M, Varma R. A 40-year forecast of 30 PUBLICATIONS the demographic shift in primary open-angle glaucoma in the United States. Invest Ophthalmol Vis Sci. 2012 May 4;53(5):2464-6. metabolic rate of oxygen by oxygen tension and blood flow imaging in rat. Biomed Opt Express. 2011 Sep 1;2(9):2562-8. Vajaranant TS, Wu S, Torres M, Varma R. The changing face of primary open-angle glaucoma in the United States: demographic and geographic changes from 2011 to 2050. Am J Ophthalmol. 2012 Aug;154(2):303-314.e3. Wang M, Lu AT, Varma R, Schuman J, Greenfield DS, Huang D and the Advanced Imaging for Glaucoma Study. Combining information from three anatomic regions in the diagnosis of glaucoma with time-domain optical coherence tomography. J of Glaucoma: In Press. Valyi-Nagy K, Kormos B, Ali M, Shukla D, Valyi-Nagy T. Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures. Mol Vis. 2012;18:588-92. Varma R, Bressler N, Suner I, Lee P, Dolan C, Ward J, Colman S, Rubio R, and for the BRAVO and CRUISE Study Groups. Improved visionrelated function after Ranibizumab for macular edema following retinal vein occlusion: results from BRAVO and CRUISE Trials. Ophthalmology 2012;119(110):2108-2118. Varma R, Lee PP, Goldberg I and Kotak S. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol 2011;152(4):515-22. Varma R, Wang D, Wu C; Francis BA; Nguyen BB; Chopra V, Memarzadeh F, Torres M and Azen SP on behalf of the LALES Group. Four-year incidence of open-angle glaucoma and ocular hypertension: The Los Angeles Latino Eye Study. Am J Ophthalmol 2012;154(2): 315-325.e1 Vasaiwala R, Sajja K, Setabutr P. Novel management of the microphthalmic orbit in a patient with PHACE syndrome. Ophthal Plast Reconstr Surg. 2011 Nov;27(6):e156-8. Wagner H, Chalmers RL, Mitchell GL, Jansen ME, Kinoshita BT, Lam DY, McMahon TT, Richdale K, Sorbara L; CLAY Study Group. Risk factors for interruption to soft contact lens wear in children and young adults. Optom Vis Sci. 2011 Aug;88(8):973-80. Wanek J, Blair NP, Shahidi M. Outer retinal oxygen consumption of rat by phosphorescence lifetime imaging. Curr Eye Res. 2012 Feb;37(2):132-7. Wanek J, Teng PY, Albers J, Blair NP, Shahidi M. Inner retinal Wang Y, Fawzi AA, Varma R, Sadun AA, Zhang X, Tan O, Izatt JA and Huang D. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci 2011;52(2):840-5. Wang Y, Fawzi AA, Varma R, Sadun AA, Zhang X, Tan O, Izatt JA, and Huang D. Pilot study of optical coherence tomography measurement of retinal blood flow in retina and optic nerve diseases. Invest Ophthalmol Vis Sci 2011;52:840-845. Wanek J, Zelkha R, Lim JI, Shahidi M. Feasibility of a method for en face imaging of photoreceptor cell integrity. Am J Ophthalmol. 2011 Nov;152(5):807-14.e1. Welder JD, Bakhtiari P, Djalilian AR. Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis. Case Rep Ophthalmol Med. 2011;2011:576521. Wen G, McKean-Cowdin R, Varma R, Tarczy-Hornoch K, Cotter S, Borchert M, and Azen S. The general health- related quality of life in preschool children with strabismus or amblyopia: The Multi-Ethnic Pediatric Eye Disease Study. Ophthalmology 2011;118(3):574580. Xie A, Yan J,Y ue L, Feng F, Mir F, Abdel-Halim H, Chebib M, Le Breton GC, Standaert RF, Qian H, Pepperberg DR. 2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-1 receptors. Mol Pharmacol. 2011 Dec;80(6):965-78. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O’Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J,Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY; Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012 Mar;35(3):556-64. Ying H, Yue BY. Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol. 2012;294:223-58. Yonekawa Y, Varma R, Choudhury F, Torres M, Azen SP, and the Los Angeles Latino Eye Study Group. Risk factors for four-year incident visual impairment and blindness: The Los Angeles Latino Eye Study. Ophthalmology 2011; 118(9):1790-7. Zaidi Q, Ennis R, Cao D, Lee B. Neural locus of color afterimages. Curr Biol. 2012 Feb 7;22(3):220-4. Epub 2012 Jan 19. Zernant J, Schubert C, Im KM, Burke T, Brown CM, Fishman GA, Tsang SH, Gouras P, Dean M, Allikmets R. Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci. 2011 Oct 31;52(11):8479-87. Zheng L, Teng E, Varma R, Mack WJ, Mungas DM, Lu PH, and Chui HC. Chinese-language Montreal cognitive assessment for Cantonese or Mandarin speakers: age, education, and gender effects. International Journal of Alzheimer’s Disease 2012: Article ID 204623, 10 pages, doi:10.1155/2012/204623. Book Chapters 07.01.2011–06.30.2012 A ref AA, Gedde SJ, Budenz DL. Glaucoma drainage implant surgery. In: Bettin P, Khaw PT, eds. Glaucoma Surgery. Basel: Karger; 2012:37-47. Chang JH, Hou JH, Jain S, Azar DT. Strategies in modulating lymphedema. In: Novel Strategies in Lymphedema. INTECH Open Access Publisher, 2012. Edward DP, Vajaranant TS. Glaucoma. Oxford: Oxford University Press, 2012. Goodwin JA. Transient visual loss. In: Gilman S, editor-in-chief. MedLink Neurology. San Diego: MedLink Corporation. First published in 2001, updated annually. Goodwin JA. Leber hereditary optic neuropathy. In: Gilman S, editor-in-chief. MedLink Neurology. San Diego: MedLink Corporation. First published in 1997, updated annually. Goodwin JA. Painful ophthalmoplegia. In: Gilman S, editor-in-chief. MedLink Neurology. San Diego: MedLink Corporation. First published in 1995, updated annually. Goodwin JA. Temporal arteritis. In: Gilman S, editor-in-chief. MedLink Neurology. San Diego: MedLink Corporation. First published in 1996, updated annually. Goodwin JA. Vogt-KoyanagiHarada syndrome. In: Gilman S, editor-in-chief. MedLink Neurology. San Diego: MedLink One Vision 2012 31 Corporation. First published in 1996, updated annually. Lisch W, Traboulsi EI, Azar DT. Corneal dystrophies. In: Traboulsi, Elias I. Genetic Diseases of the Eye. Oxford: Oxford University Press; 2012. Miller MT, Shah H, Newlin A. Craniofacial syndromes and malformations. In: Wright KW, Strube YNJ. Pediatric Ophthalmology and Strabismus. New York: Oxford University Press, 2012. Nayeb-Hashemi N, Tu EY, Azar DT. Correction of presbyopia with monovision. In: Pallikaris I, Plainis S, Charman WN. Presbyopia: Origins, Effects, and Treatment.Thorofare, NJ: SLACK; 2012. Porter IW, Azar DT. Correction of astigmatism by laser keratectomy. In: Henderson, Bonnie An, and James P. Gills. A Complete Surgical Guide for Correcting Astigmatism: An Ophthalmic Manifesto. Thorofare, NJ: SLACK Inc, 2011 Putterman AM. Forward. In: Massry GG, Murphy MR, Azizzadeh B. Master Techniques in Blepharoplasty and Periorbital Rejuvenation. New York: Springer; 2011:v. Putterman AM. Cheek-midface lift. In: Hartstein ME, Wulc AE, Holck DE. Midfacial Rejuvenation. New York: Springer Science + Business Media, LLC, 2012:49-64. Setlur VJ. Lens-induced uveitis. In: Maguire JI, Murchison AP, Jaeger EA. The Wills Eye Institute 5-Minute Ophthalmology Consult. Philadelphia: Lippincott Williams & Wilkins, 2011. Strömland K, Miller MT. Teratogens and ocular malformations. In: Traboulsi, Elias I. Genetic Diseases of the Eye. Oxford: Oxford University Press, 2012. ARVO Meeting Abstracts 05.06.12–05.10.12 Allemann N, Fahd D, Chamon W, Chang J, Jain S, Azar DT. Impediment to whole eye transplantation: An animal model and surgical techniques. ARVO Meeting Abstracts 2012;53:293. Antoine TE, Shukla D. Non-muscle myosin IIA mediates HSV-1 entry into the cells of the human and pig corneas. ARVO Meeting Abstracts 2012;53:6153. Bui KM, Garcia-Gonzalez JM, Lin A, Patel S, Goldstein DA, Edward DP. Directed conjunctival biopsy and impact of histologic sectioning methodology in the diagnosis of sarcoidosis. ARVO Meeting Abstracts 2012;53:3215. Sajja K, Putterman AM. Posterior approach ptosis repair in the aesthetic patient with or without blepharoplasty, In: Massry GG, Murphy MR, Azizzadeh B. Master Techniques in Blepharoplasty and Periorbital Rejuvenation. New York: Springer; 2011:137-146. Burdi RA, Wagner E, Walker L, Grybauskas A, McCarty RD, Mayer JP, Knepper PA. Hemopexin: An inhibitor for hyaluronidase-2. ARVO Meeting Abstracts 2012;53:6616. Schmidt-Erfurth, Ursula, Williams GA, and Mieler WF. Encyclopedia of Ophthalmology. Berlin: Springer, 2012. Setlur VJ, Ohsie L. Neuroophthalmology. In: Gerstenblith AT, Rabinowitz MP. The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease. Philadelphia: Lippincott Williams & Wilkins, 2012. Setlur VJ. Acute anterior uveitis. In: Maguire JI, Murchison AP, Jaeger EA. The Wills Eye Institute 5-Minute Ophthalmology Consult. Philadelphia: Lippincott Williams & Wilkins, 2011. Bold: Regular Faculty Setlur VJ. Hard exudates. In: Maguire JI, Murchison AP, Jaeger EA. The Wills Eye Institute 5-Minute Ophthalmology Consult. Philadelphia: Lippincott Williams & Wilkins, 2011. Burke TR, Fishman GA, Tsang SH, Smith T, Ayyagari R, Koenekoop RK, Iannaccone A, Cremers FP, Klaver CC, Allikmets R. Retinal phenotypes in patients homozygous for the G1961E mutation in the ABCA4 gene. ARVO Meeting Abstracts 2012;53:6442. Cao D, Zhuang X, McNamara PJ, King AC. Acute alcohol effects on mesopic rod and cone temporal processing. ARVO Meeting Abstracts 2012;53:4142. Chamon W, Ozturk O, Fahd D, Allemann N, de la Cruz J, Cortina MS, Foster C, Azar DT, Jain S. A new approach to experimentally determine human corneal Red: Volunteer and Adjunct Faculty biomechanical characteristics using OCT applied to an anisotropic finite element model. ARVO Meeting Abstracts 2012;53:6894. Chang J, Han K, Azar DT. Involvement of lysosomal proteases in VEGF-C down-regulation of VEGFR-3. ARVO Meeting Abstracts 2012;53:2394. Chang Q, Peter M, Grassi MA. Fas-mediated death of photoreceptors in A phototoxicity model. ARVO Meeting Abstracts 2012;53:2569. Chau FY, Mezu-Ndubuisi OJ, Reddy NM,Wanek J,Teng P, Blair NP, Reddy SP, Shahidi M. Spectral domain optical coherence tomography (SDOCT) findings in a mouse model of retinopathy of prematurity. ARVO Meeting Abstracts 2012;53:5885. Chow CC, Shah RJ, Lim JI, Chau FY, Hallak JA, Vajaranant TS. Effect of macular thinning, vessel tortuosity, and vessel diameter in peripapillary RNFL thickness by spectral domain OCT in sickle cell disease: Implications for glaucoma evaluation. ARVO Meeting Abstracts 2012;53:659. Cideciyan AV, Moore AT, Zrenner E, Fishman GA, Scholl HP, van den Born LI, Bittner AK, Sadigh S, Dagnelie G, Koenekoop RK. Increased vision within days of oral cis-retinoid (QLT091001) treatment in blindness due to mutations in retinal pigment epitheliumspecific protein 65kDa (RPE65) or lecithin retinol acyltransferase (LRAT). ARVO Meeting Abstracts 2012;53:6965. Fahed DS, Allemann N, Chamon W, Chang J, Jain S, Azar DT. Effect of neurotrophins and growth factors on RGC5 and an animal model of optic nerve transection in Thy1-YFP mice. ARVO Meeting Abstracts 2012;53:329. Gao X, Gauderman WJ, Marjoram P,Torres M, Haritunians T, Chen YI,Taylor KD, Rotter JI, Varma R. Genetic variants associated with central corneal thickness in latinos. ARVO Meeting Abstracts 2012;53:1550. Gaynes BI,Teng P,Wanek JM, Shahidi M. Hemorheologic and hemodynamic response of conjunctival microcirculation to acute hypotension in rabbits. ARVO Meeting Abstracts 2012;53:6834. Genead MA, Salvatore S, McAnany JJ, Fishman GA. Intrasession and intersession repeatability of retinal sensitivity using a modified nidek MP-1 microperimeter in patients with stargardt disease. ARVO Meeting Abstracts 2012;53:4370. Giovingo M, McCarty RD, Beverley R, Nolan M, Grybauskas A, Burdi RA,Wagner E, Knepper PA. DHA increases outflow resistance in porcine organ cultures. ARVO Meeting Abstracts 2012;53:2494. Godara P, Cooper RF, Diederichs MA, Sergouniotis P, Genead MA,Webster AR, Fishman GA, Han DP, Michaelides M, Carroll J. Assessing photoreceptor reflectance and structure in congenital stationary night blindness. ARVO Meeting Abstracts 2012;53:5256. Collison FT, Cao D, McAnany JJ, Genead MA, Fishman GA. Pupillary responses to offset and onset of isolated rod and cone stimuli using A 4-primary photostimulating method. ARVO Meeting Abstracts 2012;53:4823. Grace EM, Sonawane S, Khanolkar V, Katam N, Gaitonde SS, Rondelli D, Patel P, Jain S. Histopathologic and immunophenotypic characteristics of conjunctival biopsies in chronic graft versus host disease. ARVO Meeting Abstracts 2012;53:2318. Cortina MS, He J, Russ T, Erickson J, Bazan N, Bazan HE. Corneal nerve damage induces epithelial localization of vesicular glutamate transporter-2 (vglut2). ARVO Meeting Abstracts 2012;53:1793. Grassi MA,Tikhomirov A, Ramalingam S, Lee KE, Klein BE, Klein R, Lussier Y, Cox NJ, Nicolae DL. Replication analysis for severe diabetic retinopathy. ARVO Meeting Abstracts 2012;53:3330. Djalilian AR, Sagha HM, Movahedan A, Milani BY, Majdi M, Lavker RM, Yue B.The effect of notch signaling on wnt pathway genes in corneal epithelial cells. ARVO Meeting Abstracts 2012;53:1822. Grybauskas A,Wagner E, Burdi RA,Walker L, Knepper PA.TLR-4 innate immune differential response to three dietary fatty acids challenged with low molecular weight hyaluronic acid, a TLR-4 Blue: Residents and Fellows 32 PUBLICATIONS ligand. ARVO Meeting Abstracts 2012;53:6615. laser iridoplasty for optic obstruction in boston keratoprosthesis. ARVO Meeting Abstracts 2012;53:6073. Han KY, Chang J, Azar DT. Proteomic profiling between MT1MMP enzymatic domain deletion and total knockout on cornea fibroblast cells. ARVO Meeting Abstracts 2012;53:4186. Hou JH, Singa R, Green SJ, Jain S, Aakalu VK, Setabutr P. Characterization of adrenergic receptor subtype gene expression in human muller’s muscle using laser-capture microdissection and quantitative polymerase chain reaction. ARVO Meeting Abstracts 2012;53:6748. Hu J, Bui KM, Patel KH, Kim H, Arruda JA, Wilensky JT, Vajaranant TS. Changes in intraocular pressure and ocular perfusion pressure during hemodialysis. ARVO Meeting Abstracts 2012;53:254. Huang D, Zhang X, Varma R, Greenfield DS, Schuman JS, Advanced Imaging for Glaucoma Study Group,. Nerve fiber layer and ganglion cell complex measurements by optical coherence tomography as risk factors for visual field progression in glaucoma. ARVO Meeting Abstracts 2012;53:2260. Huh ES, Lim JI. Macular edema associated with branch retinal vein occlusion and anti-VEGF therapy. ARVO Meeting Abstracts 2012;53:914. Kang Mieler JJ, Osswald CR, Guthrie MJ, Mieler WF. Efficacy of dexamethasone sodium phosphate nanospheres within thermo-responsive hydrogel treatment in A laser induced choroidal neovascularization animal model. ARVO Meeting Abstracts 2012;53:2267. Kashani AH, Jaime GRL, Saati S, Chader GJ, Varma R, Humayun MS.Variation in retinal vascular oxygen content among human patients: A study using computed tomographic imaging spectroscopy. ARVO Meeting Abstracts 2012;53:2167. Kim MK,Thomas JG, Ciavatta VT, Adkins AM, Hetling JR, Pardue MT. Electrical stimulation therapy preserves visual acuity and retinal ganglion cells in P23H-1 rats. ARVO Meeting Abstracts 2012;53:2442. Kinoshita BT, Chalmers RL, Mitchell GL, Jansen ME, Lam DY, McMahon TT, Richdale K, Sorbara L,Wagner H. Minus soft contact lens power progression in young myopes: A retrospective chart review. ARVO Meeting Abstracts 2012;53:4719. Knepper PA, McCarty RD, Grybauskas A, Mayer JP, Burdi RA,Wagner E, Samples JR, Liebmann JM, Ritch R. Low molecular weight hyaluronic acid and hyaluronic acid binding protein-2: A theory for hemorrhages in POAG. ARVO Meeting Abstracts 2012;53:2797. Jiang X,Wu S,Torres M, Azen SP, Francis BA, Chopra V, Nguyen BB, Varma R, Los Angeles Latino Eye Study Group,. Risk factors for four-year incidence of open-angle glaucoma:The los angeles latino eye study. ARVO Meeting Abstracts 2012;53:6378. Krakauer M, Chow C, Mieler WF, Lim JI. Scrolled epiretinal membrane: Case series of A novel OCT finding. ARVO Meeting Abstracts 2012;53:1173. Jivrajka RV, Genead MA, McAnany JJ, Chow CC, Fishman GA, Mieler WF. Early detection of functional changes using microperimetry on patients with subclinical hydroxychloroquine toxicity. ARVO Meeting Abstracts 2012;53:971. Kuchenbecker JA, Greenwald SH, Carroll J, Fishman GA, Genead MA, Connor TB, Neitz M, Neitz J. Cone isolating electroretinograms in individuals with A mutant opsin allele associated with cone dystrophy. ARVO Meeting Abstracts 2012;53:6400. Joslin CE, Hallak JA, Vajaranant TS. Five- and ten-year glaucoma incidence in the age-related eye disease study (AREDS). ARVO Meeting Abstracts 2012;53:4476. Lim JI, Niec M, Hung D,Wong V. A pilot study of combination therapy for neovascular AMD using a single injection of liquid sustained release intravitreal triamcinolone acetonide and intravitreal ranibizumab as needed. ARVO Meeting Abstracts 2012;53:2035. Kang JJ, Aref AA, Allemann N, Cortina MS, de la Cruz J. Argon Bold: Regular Faculty Red: Volunteer and Adjunct Faculty Lim JM, Hou JH, Singa R, Aakalu V, Setabutr P. Incidence and demographic characteristics of patients with different types of ptosis referred to oculoplastics at A tertiary referral center. ARVO Meeting Abstracts 2012;53:1449. Mwanza J, Sayyad FE, Aref AA, Budenz DL. Rates of false positive peripapillary and macular optical coherence tomography scans in healthy myopic eyes: Cirrus HDOCT versus RTVue-100. ARVO Meeting Abstracts 2012;53:795. Lopez-Solache I, Koenekoop RK, Ren H, Keser V, Fu Q, Genead MA, Fishman GA,Traboulasi EI,Wang H, Chen R. Mutations in Lca9 cause human congenital blindness due to leber congenital amaurosis. ARVO Meeting Abstracts 2012;53:1733. Namavari A, Sarkar J, Chaudhary SV, Ozturk O,Yco L, Sonawane S, Khanolkar V, Katam N, Hallak J, Jain S. Corneal reinnervation following surgical transection. ARVO Meeting Abstracts 2012;53:1809. Majdi M, Movahedan A,Ying H, Sagha HM, Milani BY, Shafiq MA, Lavker RM, Yue BY, Djalilian AR.The role of notch signaling pathway in corneal epithelial cell migration. ARVO Meeting Abstracts 2012;53:3544. Nolan PR, McAnany JJ.The effects of light adaptation on the harmonic components of the flicker electroretinogram. ARVO Meeting Abstracts 2012;53:5704. Malchow RP, Jacoby J, Alford ST, Qian H, Kreitzer MA.The pH-sensitive dye HAF reports an extracellular alkalinization upon stimulation of catfish horizontal cells:Testing the H+ hypothesis of lateral inhibition. ARVO Meeting Abstracts 2012;53:4304. McAnany JJ, Alexander KR, Genead MA, Fishman GA. Equivalent intrinsic noise, sampling efficiency, and contrast sensitivity in patients with retinitis pigmentosa. ARVO Meeting Abstracts 2012;53:4361. Mezu-Ndubuisi OJ,Wanek JM,Teng, Pang-yu, Chau FY, Reddy NM, Lin A, Blair NP, Reddy SP, Shahidi M. Retinal vascular oxygen tension imaging and fluorescein angiography in a mouse model of retinopathy of prematurity. ARVO Meeting Abstracts 2012;53:4689. Milani BY, Namavari A, Shafiq MA, Majdi M, Movahedan A, Sagha HM, Djalilian AR. Effect of sirolimus on proliferation and differentiation of human corneal fibroblasts. ARVO Meeting Abstracts 2012;53:1081. Miller RC, Krakauer M, Aakalu V, Ahmad A. Efficacy of combined upper eyelid blepharoplasty and resection of retro-orbicularis oculus fat resection. ARVO Meeting Abstracts 2012;53:1452. Movahedan A, Djalilian AR, Majdi M, Sagha HM, Milani BY, Lavker RM, Yue BY. Notch inhibition accelerates mouse corneal epithelial wound healing. ARVO Meeting Abstracts 2012;53:3538. Blue: Residents and Fellows Oestreicher N, Bressler NM, Colman SS, Dolan CM, Kline Leidy N, Sunness JS,Tschosik EA, Varma R, Kimel M. The functional reading independence index (FRII): A new measure of treatment benefit in geographic atrophy. ARVO Meeting Abstracts 2012;53:5441. Oltra EZ, Chow CC, Chau FY, Lim JI, Moss HE. Neurocognitive function and retinal thinning by spectral-domain optical coherence tomography in sickle cell patients. ARVO Meeting Abstracts 2012;53:1160. Osmanovic S, Hou J, Aakalu V, Setabutr P, Putterman AM. Muller’s muscle-conjunctiva resection outcomes and phenylephrine predictability in ptosis from horner’s syndrome. ARVO Meeting Abstracts 2012;53:6747. Ostheimer TA, Chow CC, Shah RJ, Hallak JA, Chau FY, Lim JI,Vajaranant TS. Rate of retinal nerve fiber layer thinning by Heidelberg SD-OCT in sickle cell disease: Implications for glaucoma evaluation. ARVO Meeting Abstracts 2012;53:239. Patel S, Echandi LV, Dodds EM, Goldstein DA. Induction of prolonged drug-free disease remission of sympathetic ophthalmia with chlorambucil therapy. ARVO Meeting Abstracts 2012;53:5502. Prickett AL, Chamon W, Bui KM, Hallak J, Bakhtiari P, Azar DT. A novel approach to determine theoretical head tilt effect on ocular cyclotorsion measurements during laser refractive surgery. ARVO Meeting Abstracts 2012;53:5570. One Vision 2012 33 of doppler FDOCT scans. ARVO Meeting Abstracts 2012;53:2187. Srivastava SK, Albini TA, Callanan D, Goldstein DA, Bena J, Nguyen QD. Outcomes of patients treated with the fluoconinole acetonide implant and standard of care therapy for non-infectious uveitis: Combined results of three clinical trials. ARVO Meeting Abstracts 2012;53:2250. Suhr KS,Warrow D, Rosenthal JL, Lee CM, Bhoomibunchoo C, Rosen RB, Seiple WH. Structural and functional correlation between multifocal electroretinography and microperimetry in hydroxychloroquine toxicity. ARVO Meeting Abstracts 2012;53:2190. Rha J, Genead MA, Godara P,Williams V, Schroeder B, Summerfelt P, Dubra A, Stepien KE, Fishman GA, Carroll J. Highresolution imaging of photoreceptor structure in choroideremia. ARVO Meeting Abstracts 2012;53:2120. Richer SP, Stiles WR, Ulanski L,Thomas C. Observation of human retinal remodeling in octogenarians with resveratrol+. ARVO Meeting Abstracts 2012;53:286. Richter GM,Wu C,Torres M, Azen SP, Varma R. 4-year incidence of cataract surgery and associated risk factors in the los angeles latino eye study (LALES). ARVO Meeting Abstracts 2012;53:2294. Roberts DK, Wilensky JT. Persistent pupillary membranes and long anterior zonules. ARVO Meeting Abstracts 2012;53:5059. Salvatore S, Genead MA, McAnany JJ, Fishman GA. Rod sensitivity loss in patients with stargardt disease and its correlation with retinal structural changes. ARVO Meeting Abstracts 2012;53:4371. Sarkar J, Chaudhary SV, Namavari A, Ozturk O,Yco L, Sonawane S, Khanolkar V, Batta P, Hallak J, Jain S.Topical benzalkonium chloride treatment causes corneal neurotoxicity. ARVO Meeting Abstracts 2012;53:1806. Shafiq MA, Milani BY, Majdinasab M, Yue BY, Djalilian AR. Evaluation of decellularized human cornea in a mouse model. ARVO Meeting Abstracts 2012;53:292. Shah M, Zhang X, Varma R, Greenfield DS, Schuman JS, Huang D, AIGS Group . Baseline nerve fiber layer and ganglion cell complex thickness by optical coherence tomography as risk factors for the development of glaucomatous visual field defects. ARVO Meeting Abstracts 2012;53:235. Shah RJ, Lim J. Enhanced depth imaging optical coherence tomography in sickle cell disease. ARVO Meeting Abstracts 2012;53:2645. Shahidi M, Mohammad F,Wanek J, Lim JI, Zelkha R. Enface outer retinal imaging in age-related macular degeneration. ARVO Meeting Abstracts 2012;53:4110. Shen W, Purpura LA, Nan C, Chang I, Ripps H. Regulation of synaptic transmission at the photoreceptor terminal: A novel role for the cation-chloride cotransporter NKCC1. ARVO Meeting Abstracts 2012;53:5267. Shukla D,Tiwari V. Non-professional phagocytosis can play A role in herpesvirus entry into ocular cells. ARVO Meeting Abstracts 2012;53:6161. Sivaraman KR, Hou JH, Allemann N, De la Cruz J, Cortina MS. Retroprosthetic membrane thickness and risk of melt in patients with type I boston keratoprosthesis. ARVO Meeting Abstracts 2012;53:6068. Srinivas S,Tan O, Varma R, Nittala MG, Huang D, Sadda SR. Effect of quality parameters on validity Sun W, Gangaputra S, Cleary PA, Grassi MA, Benz W, Hubbard L, Davis MD, Epidemiology of Diabetes Interventions and Complications (EDIC),. Reliability of patient reporting of pan-retinal photocoagulation (PRP) compared to fundus photograph assessment in sixteen years of the epidemiology of diabetes interventions and complications study (EDIC). ARVO Meeting Abstracts 2012;53:2884. Vajaranant TS, Hallak JA, Joslin CE. Intraocular pressure and ocular perfusion pressure among 10-year incident glaucoma cases in the agerelated eye disease study (AREDS). ARVO Meeting Abstracts 2012;53:6363. Varma R, Bressler NM, Doan Q, Lee PP, Suner IJ, Danese M, Dolan CM,Turpcu A,Ward J, Ehrlich JS. Cases of legal blindness and visual impairment avoided using ranibizumab for diabetic macular edema in the united states. ARVO Meeting Abstracts 2012;53:5739. Vazquez LE,Torres M,Wu C, McKean-Cowdin R, Varma R. Risk polymorphism in SERPING1 and primary open angle glaucoma:The los angeles latino eye study (LALES). ARVO Meeting Abstracts 2012;53:3866. Vincent AL, Carroll J, Fishman GA, Sharp D, Summerfelt P, Williams V, Dubra A, Dubis AM,Wong F. Retinal structure and function in a pedigree cosegregating achromatopsia and a rhodopsin mutation. ARVO Meeting Abstracts 2012;53:4591. Tan O, Zhang X, Varma R, Huang D. Peripalliary nerve fiber layer and retinal pigment epithelium reflectance ratio for glaucoma diagnosis. ARVO Meeting Abstracts 2012;53:5618. Wagner EL, Grybauskas A, Burdi RA,Walker L, Yue B, Samples J, Knepper PA. Naloxone as a neuroprotectant in glaucoma: Its role in the TLR4 pathway and innate immunity. ARVO Meeting Abstracts 2012;53:3474. Teng P,Wanek J, Blair NP, Shahidi M. Retinal oxygen extraction fraction:The ratio of oxygen consumption to delivery. ARVO Meeting Abstracts 2012;53:2168. Wanek J,Teng P, Blair NP, Shahidi M. Global inner retinal metabolic rate of oxygen during hypoxia in rat. ARVO Meeting Abstracts 2012;53:4990. Tu EY, Shoff ME, Joslin CE.The effect of low concentrations of benzalkonium chloride on acanthamoebal survival. ARVO Meeting Abstracts 2012;53:6214. Wang M,Wu S,Wang D,Torres M, Hsu C, Azen S, Varma R, Chinese American Eye Study. Refractive error, ocular biometry, and lens opalescence:The chinese american eye study. ARVO Meeting Abstracts 2012;53:2313. Turpcu A, Colman S, Suner IJ, Bressler NM, Varma R, Lee P, Dolan C,Ward J,Yau L.The responsiveness of the national eye institute visual function questionniare-25 (NEI VFQ-25) to visual acuity gains in diabetic macular edema patients. ARVO Meeting Abstracts 2012;53:6346. Turturro SB,Ying H, Shen X, Shyam R, Yue BY. Mapping of functional consequence sites in the human optineurin gene. ARVO Meeting Abstracts 2012;53:777. Ying H, Shen X, Yue BY. Alterations in the barrier function and cell migration in stable RGC5 cell lines induced by expression of wild-type and mutated myocilin. ARVO Meeting Abstracts 2012;53:785. Yue L, Pawlowski M, Bruzik KS, Qian H, Pepperberg D. Direct activation of GABAA receptors of retinal ganglion cells by a propofol-based photoisomerizable compound. ARVO Meeting Abstracts 2012;53:279. 34 SPONSORED RESEARCH SPONSORED RESEARCH FEDERALLY SPONSORED RESEARCH Investigator Title Source Kenneth Alexander, PhD Visual Dysfunction in Retinal Degenerations National Eye Institute Dimitri Azar, MD, MBA Metalloproteinase Expression in Corneal Wound National Eye Institute Dimitri Azar, MD, MBA P30 Core Grant for Vision Research National Eye Institute Dimitri Azar, MD, MBA UIC K12 Independent Clinical Vision Scientist Development Program National Eye Institute Dingcai Cao, PhD Rod-cone Interactions in Mesopic Vision National Eye Institute Robert Chang, PhD Inhibition of VEGF Receptor Dimerization and Signaling in Corneal Lymphangiogenes National Eye Institute Ali Djalilian, MD Notch Signaling in the Corneal Epithelium National Eye Institute Jeffrey Fortman, DVM Ophthalmic Animal Facility Grant National Center for Research Resources Michael Grassi, MD Genomic and Genetic Studies of Diabetic Retinopathy National Eye Institute Sandeep Jain, MD Keratocyte Role in Guidance of Corneal Nerves National Eye Institute Charlotte Joslin, OD, PhD Local Food Environments and Disparities in Ovarian Cancer Survival National Institute on Minority Health and Health Disparities, Center of Excellence Program J. Jason McAnany, PhD Mechanisms Limiting Visual Performance in Retinal Degenerations National Eye Institute David Pepperberg, PhD Development of Nanoscale Neuromodulating Platforms National Eye Institute Mahnaz Shahidi, PhD Retinal Image Quality In Retinal-Diseased Eyes National Eye Institute Mahnaz Shahidi, PhD Noninvasive Imaging of Chorioretinal Oxygen Tension National Eye Institute Mahnaz Shahidi, PhD Investigating Optical and Neural Causes of Vision Loss Department of Veterans Affairs Deepak Shukla, PhD Molecular Mechanism of HSV Entry and Spread National Institute of Allergy and Infectious Diseases Deepak Shukla, PhD Significance of Heparan Sulfate in HSV-1 Spread National Institute of Allergy and Infectious Diseases Thasarat Vajaranant, MD The Impact of Gender in Eye Diseases and Glaucoma National Eye Institute Building Interdisciplinary Research Careers in Women’s Health Program/ National Institute of Child Health and Human Development/ Office of Research on Women’s Health Beatrice Yue, PhD Cellular Processing of Optineurin, the Product of a Glaucoma Gene National Eye Institute One Vision 2012 35 FOUNDATION SPONSORED RESEARCH Investigator Title Source Vinay Aakalu, MD, MPH Lacrimal Stem Cells and Dry Eye Research American Society of Cataract and Refractive Surgery Ahmad Aref, MD Omega-3 Fatty Acid Nutritional Supplementation in the Treatment of Ocular Surface Disease Associated with Intraocular Pressure-Lowering Medications American Glaucoma Society Dimitri Azar, MD, MBA Unrestricted Grant to Department Research to Prevent Blindness Pablo Barrionuevo, PhD (Cao) Postdoctoral Fellowship International Brain Research Organization Dingcai Cao, PhD Alcohol Effects on Visual Processing in At-Risk Social Drinkers AMBRF The Foundation for Alcohol Research Dingcai Cao, PhD Mesopic Visual Function Assessment and Risk Genotypes for Age-related Macular Degeneration Midwest Eye-Banks Robert Chang, PhD Differential Binding of Endostatin-derived Peptides and VEGF-A, -B, -C and –D Short Peptides to VEGF Receptors 1, 2 and 3 via SPR in Vitro Illinois Society for the Prevention of Blindness Ali Djalilian, MD Career Development Award Research to Prevent Blindness Michael Grassi, MD Cellular Studies of Apoptosis in RP Using Small Molecule Screening and RNA Interference Foundation Fighting Blindness Joelle Hallak (Jain) BDNF Polymorphism in Dry Eye Disease and Depression Illinois Society for the Prevention of Blindness Sandeep Jain, MD Numerical and Experimental Study of Collagen Cross-linking Treatment for Keratoconus UIC Chancellor’s Discovery Fund for Multidisciplinary Research Sandeep Jain, MD Reinnervation After Corneal Surgery Eye Bank Association of America Iris Kassem, MD, PhD Fibrin Membrane Formation and Inflammation Knights Templar Eye Foundation Paul Knepper, MD, PhD Activation of Innate Immune Toll-4 Receptor in POAG American Health Assistance Foundation Hsuan Yolanda Lu (Cao) Medical Student Fellowship Fight for Sight Behrad Milani, MD (Maumenee) Gene and Mutation Identification in the Knobloch Syndrome, an Entity Combining Neural Tube Defects, Congenital High Myopia and Childhood Retinal Detachment Illinois Society for the Prevention of Blindness Paul Park (Shukla) Targeted Therapy for HSV-infected Corneas Illinois Society for the Prevention of Blindness David Pepperberg, PhD Plasmonic Nano-antennas to Enhance Light Sensitivity of Retinal Molecular Devices Designed for Vision Restoration Doheny Eye Institute/Beckman Initiative for Macular Degeneration Mahnaz Shahidi, PhD Senior Scientific Investigator Award Research to Prevent Blindness Deepak Shukla, PhD Lew R. Wasserman Merit Award Research to Prevent Blindness Deepak Shukla, PhD Novel Peptides to Understand Herpetic Damage to Human Trabecular Meshwork via Actin Rich Nanotubular Structures The Glaucoma Foundation Sanja Turturro, PhD (Yue) Delivery of Active Matrix Metalloproteinase-3 Using Microparticles Illinois Society for the Prevention of Blindness Thasarat Vajaranant, MD Structural Testing in Advanced Glaucoma American Glaucoma Society Thasarat Vajaranant, MD Mentoring for the Advancement of Physician Scientists American Glaucoma Society Hong-Yu Ying (Yue) Identification of miRNAs that Regulate the Expression of Myocilin, a Glaucoma Gene Illinois Society for the Prevention of Blindness Xiaohua Zhuang, PhD (Cao) Novel Psychophysical Assessment of Functional Loss in Pre-perimetric Glaucoma Illinois Society for the Prevention of Blindness 36 CLINICAL INVESTIGATIONS AND TRIALS Clinical Investigations and Trials Contact Lens Charlotte Joslin, OD, PhD Corneal Refractive Power Post Refractive Surgery Ellen Shorter, OD; C. Joslin Contact Lens Parameters in Keratoconus Patients at UIC, Illinois Eye and Ear Infirmary Ellen Shorter, OD; C. Joslin The Use of Daily Disposable Silicone Hydrogel Contact Lenses in Patients with Dry Eye at the University of Illinois Cornea Soledad Cortina, MD; E. Shorter Longitudinal Evaluation of Boston Keratoprosthesis Soledad Cortina, MD; J. de la Cruz Imaging Techniques for the Management of Patients with Keratoprosthesis Jose de la Cruz, MD Safety and Efficacy of the KXL System with Riboflavin 0.1% Ophthalmic Solution for Corneal Collagen-Linking in Eyes with Keratoconus Ali Djalilian, MD Changing the Fate of Skin Epithelial Cells Grown on Human Amniotic Membrane Sandeep Jain, MD Histopathologic and Immunophenotypic Characteristics of Conjunctival Biopsies in Chronic Graft-Versus-Host Disease Sandeep Jain, MD Presence of Neutrophil Extracellular Traps (NET) in Dry Eye Disease Sandeep Jain, MD Presence of Proteins and Enzymes in Lacrimal Gland Sandeep Jain, MD Symptom Analysis of Dry Eye Disease Joel Sugar, MD Compassionate Use of the Ophtec 311 Artificial Iris Lens Implant Joel Sugar, MD Cornea Donor Study – 10 year follow-up Joel Sugar, MD; E. Tu Fuch’s Endothelial Corneal Dystrophy Study Elmer Tu, MD; S. Cortina Cornea Preservation Time Study Elmer Tu, MD Parasitic Ulcer Treatment Trial (Planning Stage) Elmer Tu, MD; W. Mieler Results of Cataract Surgery in Patients with Retinitis Pigmentosa Glaucoma Thasarat Vajaranant, MD; J. Wilensky; M. Lunde Comparing the Effectiveness of Treatment Strategies for (Primary) Open-Angle Glaucoma Registry in Glaucoma Outcome Research (RiGOR) Thasarat Vajaranant, MD Estrogen Deficiency and Risk for Premature Aging of the Optic Nerve and Glaucoma Thasarat Vajaranant, MD Structure and Function of the Optic Nerve in Glaucoma Jacob Wilensky, MD Clinical Experience with Transscleral Laser Cyclotherapy Neuro-Ophthalmology Heather Moss, MD, PhD Afferent Visual Function in Amyotrophic Lateral Sclerosis Heather Moss, MD, PhD A Phase 1-Open-label, Dose Escalation Trial of QPI-1007 Delivered by Single Intravitreal Injection to Patients with Optic Nerve Atrophy (Stratum I) and Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) (Stratum II) Heather Moss, MD, PhD A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Heather Moss, MD, PhD Prospective Evaluation of Retinal Hemodynamics in Humans With and Without Papilledema Heather Moss, MD, PhD Prospective Study to Determine the Proportion of Patients with Isolated Third, Fourth and Sixth Nerve Palsies of Microvascular versus Non-Microvascular Etiology Heather Moss, MD, PhD Retrospective Evaluation of Optical Coherence Tomographic Imaging of Optic Nerve Head Evaluation Red indicates a sponsored clinical trial. Filled rows indicate open patient enrollment. One Vision 2012 37 Oculoplastic Surgery Vinay Aakalu, MD, MPH Lacrimal and Accessory Lacrimal Tissue Gene Expression Vinay Aakalu, MD, MPH Ocular Trauma Score and Visual Acuity Outcomes in Ocular Paintball Injuries Pete Setabutr, MD Biopsy-Proven Ocular Sarcoidosis: A Descriptive Study Pete Setabutr, MD Elemental Peri-Orbital Tissue Gene Expression Analysis Pete Setabutr, MD Oculoplastic Considerations in Keratoprosthesis Surgery Pete Setabutr, MD Roof Pad Sculpting in Upper Blepharoplasty Pediatric Ophthalmology & Adult Strabismus Iris Kassem, MD, PhD Pediatric Eye Disease Investigator Group Iris Kassem, MD, PhD Positional Changes in Preoperative Measurements for Pediatric Cataract Surgery Irene Maumenee, MD; T. Vajaranant Ocular Manifestations of Connective Tissue Diseases Aisha Traish, MD Candidate Gene Screening in Peters’ Anomaly: A Study of Two Pedigrees Combining Dominant Cataracts and Peters’ Anomaly Retina Yannek Leiderman, MD, PhD Biomarkers in Proliferative Retinopathies Yannek Leiderman, MD, PhD Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski A 1-Month, Multicenter, Observational Study to Evaluate the Degree of Ocular Inflammation Associated with Pars Plana Vitrectomy Jennifer Lim, MD A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema (Protocol T) Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski A Double-Masked, Randomized, Active-Controlled Study of the Efficacy, Safety and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]) in Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski Effect of Diabetes Education during Retinal Ophthalmology Visits on Diabetes Control (Protocol M) Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (Protocol N) Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski Genes in Diabetic Retinopathy Project Jennifer Lim, MD Genetics of AMD in African Americans Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema (Protocol I) Jennifer Lim, MD; L. Ulanski Maculopathy Jennifer Lim, MD Optical Coherence Tomographical Retinal Thickness Analysis of Sickle Cell Patients Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski An Open-Label Study of the Safety and Tolerability of Combining IBI-20089 (Triamcinolone Acetonide Intravitreal Injection) When Used Adjunctively with Lucentis® 0.5 mg Intravitreal Injection in Subjects with Subfoveal Neovascular Age-Related Macular Degeneration Jennifer Lim, MD; Y. Leiderman; F. Chau; L. Ulanski A Randomized, Double Masked, Controlled Phase 3 Study of the Efficacy, Safety and Tolerability of Repeated Intravitreal Administration of VEGF Trap-Eye in Subjects with Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) Jennifer Lim, MD; L. Ulanski Ranibizumab Therapy For Choroidal Neovascularization Associated With Angioid Streaks Jennifer Lim, MD A Retrospective Case Series to Assess the Efficacy of Anti-VEGF Therapy in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion William Mieler, MD Early Detection of Functional Changes Using Microperimetry in Patients with Subclinical Hydroxychloroquine (Plaquenil) Toxicity William Mieler, MD Ocular Complications of Vaginal Mesh Implants William Mieler, MD Radiation-Induced Maculopathy following Brachytherapy Treatment of Uveal Melanoma William Mieler, MD Results of Brachytherapy Treatment of Uveal Melanoma Lawrence Ulanski, MD A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 ug and 30 ug Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Diabetic Macular Edema Lawrence Ulanski, MD Age-Related Eye Disease Study 2 (AREDS2): A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polysaturated Fatty Acids Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) in Age-Related Macular Degeneration Lawrence Ulanski, MD Home Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device To learn more about any of these investigations and trials, including how to refer patients, please call (312) 996-6591. 38 RESIDENTS AND FELLOWS ophthalmologists in training Residents THIRD YEAR SECOND YEAR FIRST YEAR Kelly Bui, MD MD—University of Washington Janet Lim, MD, MBA MD—University of California-Irvine Michael Andreoli, MD MD—Boston University School of Medicine Joshua Hou, MD MD—Washington University, St. Louis Randee Miller, MD MD—Wayne State University School of Medicine Asim Farooq, MD, MPH MD—University of Illinois College of Medicine-Chicago Sara Huh, MD MD—Case Western Reserve University Senad Osmanovic, MD MD—Northwestern University Sachin Jain, MD MD—University of Illinois College of Medicine-Peoria Renu Jivrajka, MD MD—USC Keck School of Medicine Kevin Patel, MD MD—University of Illinois College of Medicine-Chicago Bryan Kim, MD MD—University of Washington School of Medicine Joann Kang, MD MD—Columbia University Chief Resident Adam Prickett, MD MD—Stanford University School of Medicine Ernest Lee, MD MD—Dartmouth Medical School Kavitha Sivaraman, MD MD—Washington University, St. Louis Kaitlyn Wallace, MD MD—University of Chicago-Pritzker Erica Oltra, MD MD—Penn State College of Medicine Chief Resident One Vision 2012 39 Clinical Fellows CORNEA GLAUCOMA OCULOPLASTIC SURGERY RETINA Scott Kelly, MD, MPH MD—University of Texas HSC at Houston Chirag Patel, MD MD—Indiana University School of Medicine-Indianapolis Rakesh Patel, MD MD—Medical Universtiy of South Carolina, Charleston Clement Chow, MD MD—University of Wisconsin School of Medicine CORNEA NEURO-OPHTHALMOLOGY Peter MacIntosh, MD MD—Chicago Medical School, Roslind Franklin University PEDIATRIC OPHTHALMOLOGY RETINA Samuel Lee, MD MD—Loma Linda University School of Medicine Senem Salar, MD MD—Hacettepe University Faculty of Medicine, Ankara, Turkey Vikram Setlur, MD MD—University of Illinois College of Medicine-Chicago 40 RESIDENTS AND FELLOWS Former residents return Pediatric Ophthalmology & Adult Strabismus Service Javaneh Abbasian, MD, and Genie Bang, MD, joined the Pediatric Ophthalmology & Adult Strabismus Service as Assistant Professors of Ophthalmology. Both doctors were residents from 2008-2011 at the Illinois Eye and Ear Infirmary, UIC Department of Ophthalmology & Visual Sciences. Javaneh Abbasian, MD, has long standing ties to UIC and the Chicago area. She earned her BA in Biology at Northwestern University and her medical degree at UIC’s College of Medicine. She served as Chief Resident in Ophthalmology from 2010–11. She did her pediatric ophthalmology fellowship at Children’s Hospital of Philadelphia. “As a resident, I had the chance to be among an excellent group of mentors who paved the way for me and will now be my colleagues,” says Dr. Abbasian. Genie Bang, MD, received her medical degree from the University of Minnesota Medical School-Twin Cities. She holds a BS in Biology from Brown University. After completing her residency at the Infirmary, she moved on to a fellowship in Pediatric Ophthalmology & Strabismus at the Mayo Clinic. “The Infirmary is a great environment in which to start my career, and I hope to contribute as much as I have received,” says Dr. Bang. If you wish to make a gift to support resident education, please contact the Department at (312) 996-6591, email [email protected], or visit our website: IllinoisEyeAndEarInfirmary.com Illinois Eye and Ear Infirmary Residency Program UIC Alumni Anniversary Classes 2012 65th anniversary Resident Class of 1947 Nathan H. Miller, MD† Sidney W. Penn, MD James D. Stratton, MD† Florence A. Walters, MD 60th anniversary Resident Class of 1952 Frank D. Berry, MD George T. Fitzgerald, MD Margaret A. Halle, MD Clarence L. Hans, MD Morton R. Kahn, MD Max Kaplan, MD† J. Harley Quint Jr., MD Taylor Smith, MD Dana O. Troyer, MD† 55th anniversary Resident Class of 1957 Robert Azar, MD Alina A. Domanskis, MD† Edward B. Lazor, MD John H. Panton, MD Judith V. Perry-Smith, MD Karl Ticho, MD 50th anniversary Resident Class of 1962 William M. Adler, MD Richard E. Berge, MD Curtis Deters, MD Ronald S. Fishman, MD Donald J. Holzberg, MD Theodore Lawwill, MD Joseph M. Robbins, MD† Paul J. Schmidt, MD† Richard F. Schwerdt, MD† Richard J. Underriner, MD† 45th anniversary Resident Class of 1967 Irineo P. Acacio Jr., MD James S. Close, MD Bernard Davidorf, MD Victor Feldman, MD N. Warren Hindle, MD Donald J. Kozil, MD Michael P. Lipsich, MD Mary L. Spitzer, MD Charles Vygantas, MD 40th anniversary Resident Class of 1972 Yee-Sheng Chiu, MD Frank R. Guastella, MD John Hattenhauer, MD Stephen Herman, MD Felipe Huamonte, MD Alexandra M. Ilkiw, MD John F. Kwinn, MD Robert Lennon, MD Sally R. Oakes, MD Yoshitaka Obara, MD Paul R. Rice, MD Thomas S. Stevens, MD Howard Tessler, MD Michael B. Woolf, MD 35th anniversary Resident Class of 1977 Alan J. Axelrod, MD Krystyna H. Berry, MD Robert C. Fletcher, MD Walter I. Fried, MD, PhD Nayan V. Gandhi, MD James L. Green, MD Sherwin J. Isenberg, MD Harvey K. Minatoya, MD Donald R. Sanders, MD George J. Witteman, MD Shin Yoneya, MD 30th anniversary Resident Class of 1982 Daniel B. Feller, MD David J. Fuerst, MD Edward J. Goldman, MD Claudio P. Juarez, MD Marc Lieberman, MD Michael Lieppman, MD John J. McGetrick, MD Paul A. Mahlberg, MD Paul A. Sieving, MD, PhD Robert Weinreb, MD 25th anniversary Resident Class of 1987 Mary P. Collins, MD Douglas G. Day, MD Janis I. Dzelzkalns, MD R. Mark Hatfield, MD Cheryl B. Kraff-Cooper, MD Paul F. Nichols, MD Ann K. Williams, MD Douglas P. Williams, MD 20th anniversary Resident Class of 1992 Brian S. Biesman, MD SueEllen Colby, MD Daniel J. Green, MD Balaji K. Gupta, MD Michael Janowicz, MD Eugene Liu, MD Michael E. Mockovak, MD Peter K. Rabiah, MD Bruce Saran, MD 15th anniversary Resident Class of 1997 Charles Ahn, MD Frank Caserta, MD Teresa Chen, MD Joseph Garber, MD Peggy Gramates, MD Rachael Greenberg, MD Gregory Nelson, MD Ashok Penmatcha, MD Daniel Taglia, MD 10th anniversary Resident Class of 2002 Vandana Badlani, MD Bruce Buerk, MD Faisal Haq, MD Sukesh Kansal, MD Mona Khan, MD Nighat Khan, MD Hemang Patel, MD Raju Sarwal, MD Thao Tran, MD Phillip Wu, MD 5th anniversary Resident Class of 2007 Mauricio Chavez, MD Manishi Desai, MD Jeremy Keenan, MD, MPH Janet Lee, MD Theodore Lin, MD Marcus Muallem, MD Names in italics have made a donation to support resident education. †Deceased The Department of Ophthalmology & Visual Sciences wishes to thank the following individuals for support of Resident Education in 2012. Anonymous Alumnus Daniel C. Alter, MD, PhD Brian S. Biesman, MD Norbert M. Becker, MD, Res’87 Bruce Buerk, MD Teresa Chen, MD Janis I. Dzelzkalns, MD Walter J Fried, MD, PhD David J. Fuerst, MD Frank R. Guastella, MD Bajali K. Gupta, MD John M. Hattenhauer, MD R. Mark Hatfield, MD Sherwin J. Isenberg, MD Sukesh Kansal, MD Jeremy Keenan, MD, MPH Janet Lee, MD David Lubeck, MD Marcus Muallem, MD Paul F. Nichols, MD John H. Panton, MD Donald R. Sanders, MD Raju Sarwal, MD Paul A. Sieving, MD, PhD Donald Smart, MD Judith Perry Smith, MD, Res’57 Ann K. Williams, MD Douglas P. Williams, MD George J. Witteman, MD Wilson Ophthalmics Illinois Eye and Ear Infirmary UIC Department of Ophthalmology & Visual Sciences College of Medicine 1855 West Taylor Street Chicago, IL 60612 upcoming symposia 2013 March 16–22 Illinois Eye Review 2013 22 2013 Retina Symposium May 22 2013 Spring Glaucoma Symposium June 21 37th Annual Alumni / Resident Day July 12–14 International Children’s Anophthalmia and Microphthalmia Network Annual Meeting Hosted by Pediatric Ophthalmology & Adult Strabismus September 13–14 2013 Cornea Symposium 21 Pediatric Ophthalmology for the Non-Ophthalmologist October 2 3rd Biennial Neuro-Ophthalmology Symposium www.IllinoisEyeAndEarInfirmary.com
